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Breast cancer and its most radical treatment, the mastectomy, significantly impose 
both physical transformations and emotional pain in thousands of women across the 
globe. Although reconstructive surgery is viewed as a possible recovery route for a 
lost symmetry and gender identity, it provides these patients with a breast mound 
whose most notable feature is scarring from the initial invasive procedure.  Restoring 
the appearance of a nipple-areola complex directly on the breast represents an 
important psychological healing experience for these women and remains an 
unresolved clinical challenge, as current restorative techniques using Skin Flap 
Suturing (SFS) renders a flattened disfigured skin tab within a single year and 
requires subsequent surgeries.  A tissue-engineered scaffold designed to integrate 
with the breast skin can not only aid in the development of a more robust and 
aesthetically pleasing nipple but can also aid in minimizing the patients’ prominent 
  
mastectomy scars.  As 3D printing has become a popular and advantageous way to 
produce scaffolds with complex, patient-specific structures, this technology holds 
great promise for the fabrication of custom shaped nipple-areola grafts per any breast 
size.  The work presented here is aimed at the development of a hybrid scaffold, 
composed of complementary biodegradable and synthetic hydrogels, that fosters the 
regeneration of a viable dermal layer in the form of a nipple-areola complex. The first 
aim of this research defined a dynamic dual bioink 3D printing strategy to produce 
soft tissue grafts that allow for enhanced host integration and volume retention.  A 
new shape analysis technique utilizing CloudCompare software was also 
demonstrated to expand our available toolbox for assessing scaffold aesthetic 
properties.  We then extended both modular printing and shape assessment techniques 
to the fabrication of a nipple-areola scaffold in the second aim, where both structural 
and bioactive components of the design were further adjusted.  Lastly, the third aim 
explored the immune and vascular responses to these hybrid materials in a rigorous 
evaluation of an in vivo rat subcutaneous implantation study.  Envisioned as 
subdermal implants, these nipple-areola bioprinted scaffolds have the potential to 
reduce subsequent surgical intervention by creating a lasting nipple-areola structure 
that harmoniously coexists with the patient’s breast skin. The proposed system can be 
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Chapter 1: Introduction to Nipple Reconstruction 
 
1.1 Breast Cancer and its Threat on Nipple Tissue Health 
With the latest estimate of 276,4801 new cases of invasive breast cancer 
occurring each year in the US, many female patients will face this malignant disease 
even with early diagnosis by annual mammographic screening.  Breast cancer first 
begins at a single local site, most commonly in the cell lining of the lactiferous ducts 
(connection of lobules to the nipple, 80% of breast cancer cases), but can quickly 
break through the walls of the mammary glands or ducts and spread into the 
surrounding breast tissue (Figure 1.1).  These abnormal cells can then infiltrate into 
the axillary lymph nodes and further to distant organs including the liver, lungs, 
pancreas, spleen, kidney, skin, heart, thyroid, ovary, bones, and brain2.  Once the 
cancer begins to metastasize, most patients must undergo surgical treatment 
(commonly modified radical mastectomy, breast conserving surgery, or nipple-
sparing mastectomy) on top of adjuvant therapies (cytotoxic chemotherapy, hormonal 
therapy, radiation therapy, targeted therapy, and immunotherapy) to resect the 
affected tissue and eradicate the remaining breast tumor cells that have spread to 
distant sites by the time of diagnosis3,4.  The entire treatment process has a wide range 
of acute and long-term side effects that substantially affect the patient’s quality of 
life5,6.  Some of these side effects include peripheral neuropathy, dental issues, 
musculoskeletal symptoms, heart problems, menopausal symptoms, lymphedema, 





with local and systemic treatment, approximately 40% of patients relapse and can 
ultimately die from metastatic breast cancer2.   
 
A significant number of patients (58%)10 choose to have their breast tissue removed 
via mastectomy to avoid the negative side effects of adjuvant therapy and decrease 
the likeliness of cancer recurrence.  There are several types of mastectomy surgical 
treatments, including simple mastectomy (SM, removal of entire breast and overlying 
skin), modified radical mastectomy (MRM, combines SM with removal of axillary 
lymph nodes), radical mastectomy (RM, combines MRM with removal of chest 
muscles), and skin-sparing mastectomy (SSM, involves removal of breast tissue, 
nipple, and areola, but most of the skin over the breast is saved and used only when 
breast reconstruction is performed immediately after the surgery)11.  The most 
common mastectomy performed is the MRM, as SM and SSM are reserved for 
patients with small tumors that are not close to the surface of the skin and RM is an 
extensive surgery reserved for patients with tumors growing into the pectoral 
muscles.  Alternatively, breast-conserving surgery (BCS, commonly known as a 
lumpectomy), where only the cancerous tissue is removed from the chest, has been 
developed to reduce the psychological distress of the patient and avoid 
postmastectomy syndrome and has been increasingly popular in the past two decades 
for low-risk procedures (i.e. cases where cancer has been locally contained and >5 cm 
from the nipple-areola complex).  However, it is generally not an option in patients 
with a high tumor-to-breast ratio, those with multicentric cancers, or those with 






Figure 1.1: Schematic Representation of Breast Cancer and its Various 
Treatments. A. The most common form of invasive breast cancer Ductal Carcinoma 
In Situ is characterized by the neoplastic proliferation of epithelial cells within the 
mammary gland lobules and ducts.  These cancer cells can quickly spread throughout 
the ductal system, threatening the health of the nipple tissue. B. Breast Conserving 





is greater than 5 cm away from the nipple-areola; however, if the cancer cells have 
metastasized into this region, the patient must undergo a C. modified radical 
mastectomy procedure. D. The most common surgical technique to resect breast 
cancer tissue in invasive BC cases is shown above, where overlying skin, axillary 
lymph nodes, nipple-areola, and all mammary gland tissue is resected from the chest 




The nipple-sparing mastectomy (NSM) is the third most common surgical technique 
that, similar to BCS, has been developed to preserve the entire nipple-areola complex 
and the breast skin envelope at the time of the mastectomy.  Again, this technique is 
reserved for early breast cancer cases that are deemed oncologically safe for the 
patient.  Currently there is no available standard protocol for NSM procedures13.  
Because of this, the surgeon is often confronted with a conflict at the time of the 
procedure; a better cosmetic outcome results if more subcutaneous fat is left after the 
resection of the breast tissue, however, all of the breasts underlying tissues must be 
completely removed to avoid the risk of disease recurrence14.  It remains difficult to 
identify the correct layer between the subcutaneous fat and glandular breast tissue, 
and thus there is a higher probability that residual tissue left after the resection may 
still contain the disease.  Some surgeons may also limit NSM procedures in patients 
with a low amount of subcutaneous fat because they are prone to experience 
noticeable wrinkling, capsular contracture, and/or skin necrosis due to insufficient 
vascularization15.       
 
In most breast cancer cases, the cancer has spread through the ductal tract of the 
mammary glands and impacts the health of the nipple tissue, resulting in the inability 





common form of preinvasive breast cancer and is characterized by the neoplastic 
proliferation of epithelial cells limited to the lactiferous ducts12.  Many surgeons 
believe that it is essential to remove the nipple-areola complex when a mastectomy is 
performed, as the breast cancer nipple-involvement can vary from 25-50% in 
published DCIS cases17,18.    
 
Systemic therapies, including chemotherapy, targeted therapy, and hormonal therapy, 
are often combined with some type of surgery but are not effective in curing the 
disease alone.  Though the risks of complications are nearly twice as high for women 
who undergo mastectomy than those in BCS procedures, many BCS-eligible women 
continue to have the invasive radical modified mastectomy (~22,000 cases/year) due 
to reluctance to undergo radiation therapy after BCS, desire for uniform aesthetic 
outcomes, and fear of cancer recurrence19.  Furthermore, women who are diagnosed 
with breast cancer in one breast are likely to choose to have the unaffected breast 
removed as well (contralateral prophylactic mastectomy)20,21. 
1.2 Psychological Effects of Mastectomy   
Breast cancer survivors are a unique group of patients that face many 
challenges, some of which include side-effects of ongoing hormone therapy (joint 
pain)22, weight gain related to adjuvant therapy23, persistent fatigue24, early 
menopause25, and psychological challenges that accompany alterations in body 
image26.  Many reports indicate that >70% of patients experience pain and depression 
posttreatment of the disease, with sleep disturbances listed as another common 





side effects, including radiation fatigue, nausea, hair loss, changes in taste, headache, 
and anxiety, can be recalled with a mere glance at the patients’ scars5,29.  
Mastectomies can be life-saving surgeries, but for better or for worse, breasts are so 
deeply tied to the identity and self-esteem that for many female patients, losing one or 
both of their breasts difficult to mentally process.     
 
There are many roads to emotional recovery, such as pharmaceutical treatments for 
depression and anxiety, psychiatric therapy, and even restorative efforts, which is 
why many doctors emphasize how important it is for women to prioritize their mental 
health at every stage of breast cancer treatment.  Supportive care programs, 
psychospiritual integrative therapy, and psychosocial support programs have been 
shown to result in reduced frequency, duration, and intensity of treatment-related 
symptoms30,31.  Many patients have found breast reconstruction increases their sense 
in quality of life, and a good majority (63%32) of all patients enduring a mastectomy 
in the US undergo these breast reconstruction procedures.  Reconstruction of the 
breast mound using silicone implants has made it possible to rebuild a mirage of the 
natural organ lost from surgery, which helps the patient psychologically heal from 
significant tissue mass loss (Figure 1.2).  Plastic surgeons have found, however, that 
the restoration of the critical visual landmark -the nipple-areola complex- is 
influential in the emotional recovery of their patients33.  Without the visual cue that 
the nipple-areola complex provides, the reconstruction is merely a mound whose most 








Figure 1.2: Schematic Representation of Breast Reconstruction.  Silicone 
implants can be placed directly above the pectoral chest wall, after the skin has been 
previously expanded via tissue expanders. The prominence of the central scar is 
magnified, and many patients undergo nipple reconstruction to lessen this effect.  
 
1.3 Skin Flap Suturing and its Common Setbacks 
To ease the physical, psychological, and social challenges breast cancer 
survivors face, nipple reconstruction using Skin Flap Suturing (SFS) has become a 
regular post-operative procedure following patient healing of the initial silicone 
implantation (typically 3-5 months, once swelling and inflammation has subsided)34 
that aims to rebuild the appearance of the new breast tissue.  The mammary glands, 
majority of breast tissue responsible for producing milk, and the lactiferous ducts, 
tubules responsible for delivering the milk to the surface of the skin, have been 
removed during the MRM procedure rendering the remaining breast tissue non-
functional.  Breast reconstruction allows the patient to rebuild the look of this tissue 
with the implantation of silicone implants within the chest wall.  Due to the loss of 





nipple to act as a vessel to transport milk and properly function.  Thus, skin located at 
the highest point of the reconstructed breast mound is incised to small skin flaps that 
are sutured together to build an elevated skin tab.  Additionally, intradermal tattooing 
is effective for creating areolar hyperpigmentation, while darker pigmented skin 
harvested from the patient’s inner thigh or groin can also be used as grafts to produce 
the characteristic coloration of the areola around the projection35. 
 
The outcome of local skin-tissue flaps is an inevitable loss of projection with 
contracture due to wound healing effects.  The sutured knot initially experiences local 
hemostasis and inflammation from leaky damaged blood vessels, triggering an influx 
of activated platelets and white blood cells to the injured site.  Immune cells have 
been shown to secrete collagenase, among other proteolytic enzymes, which 
immediately begin to degrade the forced collagen network of the knot36.  Granule 
tissue formation (fibroblast growth and deposition of new extracellular matrix by the 
excrement of collagen I and fibronectin) and epithelialization (proliferation and 
crawling of epithelial cells atop the wound bed providing a cover for the new tissue) 
are necessary for the projection to effectively heal and maintain its proper shape; 
however, wound contraction and scar formation can affect these processes37.  
Recruited myofibroblasts attempt to decrease the size of the wound by gripping the 
wound edges and contracting using cellular mechanisms similar to those of smooth 
muscle cells36.  The skin lesion is usually healed within 3 weeks; however, the end 
product is not aesthetically ideal.  A flattened disfigured skin tab results, where the 





scar tissue.  Studies comparing several SFS techniques demonstrate a disappointing 
70% loss of projection within 12 months due to complications in scar contracture, 
retraction forces from surrounding skin, and inadequate vasculature38–40.  Multiple 
incision techniques have been investigated, such as C-V flaps, Skate flaps, Star flap, 
and Purse-String Suture (Table 1.1), but regardless of the skin flap incision pattern 
used the result remains a flattened skin tab scar that these women repeatedly fix 
throughout life41–46.  The act of repetitive reconstructive surgery is yet another 
detrimental psychological challenge these women face, adding even more difficulty 
to overcoming their disease.  In order to improve clinical outcomes from nipple 
reconstruction, better technologies to control nipple flattening and a more reliable 

















SFS Documented Procedures  
Author Year Surgical Technique Notes 
Berson MI47 1946 Berson's Technique 
three identical triangular 
sections excised; margins of 
triangles are sutured together  
De Cholnoky T48 1966 Everted navel    
DiPirro ME49 1970 DiPirro Technique Modification of Berson's; four triangular wedges  
Muruci A50 1982 Double dermal-fat flap   
Barton FE Jr51 1982 Maltese-cross dermal-epidermal flap technique   
Little JW III52 1983 Quadrapod flap   
Silversmith53 1983 Silversmith Technique modification of quadrapod flap 
Hartrampf CR Jr54 1984 Omega flap   
Kon M55 1984 Three Flaps   
Chang WH56 1984 T Flap   
Cohen IK57 1986 Pinwheel Flap   
Little JW58 1988 Skate Flap   
Cronin ED43 1988 S Flap   
Kroll SS59 1989 Dual Opposing-tab-flap   
Anton LE60 1991 Star Flaps   
Jones G61 1994 C-V Flap   
Teimourian B62 1994 Propeller Flap   
Eng J63 1996 Bell Flap   
Thomas SV64 1996 Thomas Technique Cutaneous-flap with a shape of rectangular plus circle 
Rubino C65 2003 Arrow Flap Modifications to Thomas SV technique 
Gamboa-Bobadilla66 2005 Top Hat Technique   
Germano D67 2006 Fleur-de-lis Flap Technique   
Hammond DC68 2007 Skate Flap Purse-string Design   
Brackley PT61 2009 Modified C-V Flap   
Zhong T58 2009 Modified Skate Flap   
Farace F69 2010 Modified Arrow Flap   
Van Laeken N70 2011 Two-Step Purse-string Suture Technique   
Jamnadas-Khoda B71 2011 Cigar Roll Flap   
Karabagli Y72 2012 E Flap   
Elizabeth Clark S73 2014 CC-V Flap augmentation of C-V flap  
Butz DR74 2015 C-Y Trilobed Flap    





1.4 Engineering Nipple Tissue 
The technical objective of nipple reconstruction is to create the appearance of 
a nipple-areola complex that maintains projection and is symmetrical with the 
contralateral breast in terms of pigmentation and size.  Symbolically, it represents the 
final chapter of the breast reconstruction process and lends a meaningful sense of 
closure for the patient.  Previous reports have documented that nipple reconstruction 
enhances the self-esteem in patients and decreases the feeling of distress due to the 
mastectomy procedure itself75–77.   Some have even reported that women are more 
likely to undergo a mastectomy if the nipple can be reconstructed78.  Overall, this 
process undeniably provides psychological benefit to the patient, and therefore is an 
essential component in the breast reconstruction process.     
 
An ideal reconstruction of the nipple-areola complex requires symmetry in position, 
size, shape, texture, pigmentation, and permanent projection.  Even within the same 
patient, however, the nipple-areola anatomy can be remarkably variable.  The nipple 
itself may project as much as 1cm, with a diameter of approximately 4-10 mm, and 
the surrounding areola averages 3.0-4.5 cm in diameter34,79.  Its projection results 
from underlying mammary ducts that converge to one central point, producing a 
dynamic semi-rigid structure that can be stimulated (either by direct contact or neural 
stimuli) to gradually change in height.  Since a wide variability exists in dimension, 
color, and texture, the nipple-areola complex is generally regarded as the prominent 
elevated structure centered within a pigmented area located on the apex of the breast 






Several attempts have been made to address this topic using a tissue engineered 
approach.  Sprinkled throughout the past 75 years in literature, research groups have 
implanted a variety of materials to create a nipple projection, including autologous 
materials (cartilage80–83, fat84,84,85, and contralateral nipple34,86–88), alloplastic 
materials (hyaluronic acid89,90, calcium hydroxyapatite91,92, and artificial bone 
substance85), decellularized matrices (rolled dermal grafts38,93,94, cadaveric nipple 
tissue95), and synthetic materials (internal96,97 or external silicone prosthetics98–101).  
Although many claim some methods are superior to others, undesirable aspects 
persist with each method. 
 
1.4.1 Autologous Materials 
Initiated by Adams in 194487 and further described by Millard in 197288, the 
nipple-sharing method (the implantation of autologous contralateral nipple grafts) has 
remained as one of the most popular methods documented in nipple reconstruction 
history.  The results recorded excellent pigment and texture match and high patient 
satisfaction.  This procedure does have its limitations, however, as it is only applied 
to patients with 5-6mm excess projection (diagnosed as hypertrophic).  Some patients 
may also be hesitant to exchange one normal nipple for two inferior ones, and there 
are possible complications that accompany the procedure- including donor site 
morbidity, pain, scarring, infection, and loss of sensation in both the reconstructed 






Autologous cartilage tissue implantation for nipple reconstruction was first 
introduced by Brent and Bostwick in 1977103.  This first attempt resected cartilage 
from the patient’s rib at the costochondral-sternocostal joint.  Several groups followed 
suit80–83, as this implantation only averaged a 26.1% projection loss after 45 months.  
However, complications did arise, such as ischemia, infection, and further migration 
of the cartilage tissue.  Increased operative time and donor site morbidity were the 
biggest downfalls of this procedure, and many surgeons feel that the increased 
invasiveness of obtaining a graft outweighs the marginal cosmetic benefit.   
 
The autologous material that provides a nipple projection with the most natural tactile 
properties is adipose tissue.  Donor fat can be harvested from the abdominal region 
using aspiration cannulas, concentrated into 1cc syringes, and injected into a sutured 
flap84.  Unfortunately, this technique does result in loss of projection (up to 60%)104 
due to postoperative fat necrosis and inadequate vascularization.  Therefore, repetitive 
reconstruction is necessary in order for this technique to be effective.  
 
1.4.2 Alloplastic Materials 
With advancements in materials engineering, alloplastic materials have 
become the most promising matrices that can be used to produce a lasting nipple 
projection.  Hyaluronic acid stands out as the most attractive contender, as cases 
report high patient satisfaction and a projection that can be maintained for 12 
months89,90.  Injections do need to be performed at 2, 4, and 7 months to create the 





degradable.  Calcium hydroxyapatite (Radiesse) is a more robust injectable, however, 
this filler has been found to interfere with breast cancer screenings as it remains 
radiopaque in mammograms91,105.  Thus, although alloplastic material injections have 
been found to bleed into the surrounding breast tissue and may interfere with 
oncologic surveillance, they do have a clear advantage when compared to autologous 
reconstruction due their lack in donor site morbidity.   
 
Ceratite, an implant labeled as artificial bone substance, presented the highest 
complication rate (18%)85 in reported alloplastic materials.  This implant, composed 
of 20% tricalcium phosphate and 80% hydroxyapatite, was initially developed for use 
in craniomaxillofacial reconstruction106.  Unlike the injectable materials mentioned 
above, this material was implanted subdermally and resulted in flap necrosis and an 
extrusion of the artificial bone.  Other stiff implants (composed of synthetic 
polytetrafluoroethylene)107 have also been shown to extrude from the body, and it’s 
possible that the increased pressure from the nipple flap combined with the rigidity of 
the materials likely causes this extrusion. 
 
1.4.3 Decellularized Matrices 
From burn treatments to breast reconstruction, the use of acellular dermis has 
become a popular method to restore a variety of tissues.  Detergents and chaotropic 
agents such as Triton X, sodium dodecyl sulfate, and deoxycholate are used to 
carefully decellularize donor tissue, creating matrices that contain both natural 





implanted for regenerative purposes.  AlloDerm, a human-derived acellular dermis, 
has been cut and folded upon itself to create a nipple projection in previous reports.  
Although this matrix greatly guided neovascularization throughout the projection, the 
AlloDerm-augmented nipples displayed a shrinkage of 50-70% and failed to produce 
a statistically significant improvement in projection when compared to traditional 
SFS reconstruction38,93.  In addition, the cost of each AlloDerm nipple implant could 
range up to $1500, rendering it as the most expensive material that provides no 
discernible benefit for nipple projection94.   
 
This past October 2020 marked a critical timepoint in nipple reconstruction history.  
BioAesthetics, a biotechnology startup, announced that it has significantly surpassed 
its Series A $2.5 million for its premiere product NACgraft, a decellularized 
cadaveric nipple tissue implant108.  The substantial support for the NACgraft is 
exciting, as it validates the market’s need for a regenerative nipple-areola graft.  The 
group has previously shown that the residual DNA content of the NACgraft is well 
below the threshold that is comparable to commercial acellular products109,110 such as 
TissueMend, Restore, GraftJacket, and AlloDerm, and that its intact extracellular 
components of collagen, elastin, and cell-adhesion molecules aid in the acceptance of 
the graft in a Rhesus macaque study95.  One can speculate, however, that patient 
preference for the cadaveric donor tissue may waver when presented with an 






1.4.4 Synthetic Materials 
Mimicking current breast reconstructive practice, small gum-drop silicone and 
polyurethane implants have been subdermally placed in patients to create a nipple 
projection.  Unintuitively, these materials resulted in a myriad of complications.  
Patient safety was a concern due to the materials accompanying risks of hematoma, 
toxicity, allergic and immune reactions, and potential carcinogenicity97.  Silicone rods 
have also been reported to result in a 100% rate of local flap necrosis and rod 
extrusion96.  Given these outcomes, silicone implants are not regularly used in nipple 
reconstruction. 
 
In addition to implants, silicone has also been used to create external nipple 
prosthetics.  In this case, custom prosthetics offer patients a nonsurgical option for 
nipple reconstruction98,99.  A prosthetist can create a life-like nipple-areola complex 
by creating a mold from a previous impression of the contralateral nipple.  This 
silicone nipple-areola can then be attached to the breast mound with silicone tape or 
other adhesives.  Patients greatly enjoy this option because of the customization 
aspect of this process, but these prosthetics can be uncomfortable to wear and do not 
carry the benefit of an integrated persistent projection with the breast100,101.  
 
1.5 Conclusion 
In all surgical cases, the main complication that plagues nipple reconstruction 
continues to be projection flattening and poor cosmetic outcomes.  Autologous 





increased donor site morbidity and operational time.  The ease and low complication 
rate that accompany alloplastic injections render this technique favorable, yet it still 
requires constant maintenance for the patient.  Decellularized dermal matrices are 
expensive and still result in an undesirable flattened skin tab, while cadaveric tissue 
may not be a patient’s first choice when deciding which materials to use for their 
breast reconstruction process.  A customizable TE approach that incorporates the 
uniqueness of each patient and presents an opportunity to regenerate part of the breast 
may help improve patient psychological health and may be the next worthy solution.  
 
 
1.6 Dissertation Work Overview 
A surgical procedure that necessitates repeated intervention due to projection 
loss is not appropriate for the psychological health needs of breast cancer survivors. 
The development of a customizable nipple-areola tissue engineered graft capable of 
retaining its shape and mechanical features once implanted could reduce the need for 
subsequent surgical interventions, result in a more well integrated, aesthetically 
pleasing nipple, and most importantly, prioritize and support the emotional health of 
the patient.  Specifically, the aims of this work are as follows: 
1) Develop a hybrid printing technique that capitalizes on the strengths of both 
natural and synthetic bioinks 
a. Design an extrudable synthetic bioink that displays soft tissue 
mechanical properties with minimal post-print swelling 






2) Design and fabricate a nipple-areola scaffold that mimics the complex 
structure of the native nipple-areola complex 
a. Evaluate in vitro functionality of the scaffold 
b. Characterize the shape retention of the cell-laden nipple projection 
3) Demonstrate positive implant integration in a rat subcutaneous model 
a. Characterize the foreign body response and neovascularization of the 
















Chapter 2: Recent Developments in Soft Tissue Engineering1 
 
 
Soft tissue engineering is a promising TE field whose strategies can be applied to 
engineering a nipple-areola construct.  In the background information presented 
below, we first investigate the clinical strategies used to treat soft tissue defects and 
the challenges that accompany them.  Next, soft tissue engineering strategies are 
explored in terms of scaffold fabrication techniques and the materials generally used 
in each process.  Last, we dive into the most attractive technique, additive 
manufacturing, and explore the advantages and disadvantages of extrusion-based 3D 
printing.  
 
2.1 Challenges that Accompany Autologous Grafts and Soft Tissue Implants  
Similar to nipple reconstructive cases, treatment methods for soft tissue 
defects in the clinic present a number of challenges and limitations.  These defects 
may occur due to several causes, ranging from simple contour incongruencies due to 
congenital deformities to large volume tissue loss following deep burns, trauma, or 
tumor resection.  The term ‘soft tissue’ can refer to both connective tissues (such as 
tendons, ligaments, skin, adipose, cartilage, and synovial membranes) and non-
connective tissues (such as muscles, nerves, and blood vessels)111.  Because soft 
tissue defects range in size, shape, and tissue composition, there is no single solution 
capable of reconstructing replacement tissue with identical volume and mechanical 
 
1 Adapted from: Van Belleghem SV, Mahadik B, Snodderly K, Fisher JP, “Overview of Tissue 





properties.  Current clinical techniques fill most soft tissue voids with either natural 
materials, such as free adipose tissue grafts and autologous dermal fat flaps, or 
synthetic materials, such as commercially available silicone implants112,113.  
Unfortunately, all these strategies present significant setbacks.  Though free adipose 
tissue can be resected safely with a minimally invasive procedure, the autologous fat 
transfer experiences significant volume augmentation due to the limited survival of 
mature adipocytes post liposuction trauma.  Contour irregularity, lumpiness, and graft 
resorption make this grafting technique inefficient and unsuccessful114.  Dermal flat 
flap harvest, a technique that completely resects large sections of skin and fat tissue in 
attempt to retain its vasculature and structure, is a technique limited by the donor site 
and can lead to site morbidity, pain, scarring, and often experience shrinkage and 
fibrosis post implantation115–117.  Silicone implants have the advantage of 
permanently retaining mechanical properties; however, they do not integrate with the 
surrounding host tissue and are commonly associated with implant migration, rupture 
and/or breakdown, and fibrotic encapsulation from the immune system’s foreign body 
response118,119.  In some cases, the encapsulation causes a significant pain and an 
undesirable contortion of the implant, and further surgical intervention is needed to 
restore the area.  The contortion of silicone implants used for breast reconstruction 
have been reported to cause spontaneous leakage of silicone gel, and these synthetic 
molecules can migrate into vital organs including the brain and spinal cord, the 
lymphatic stream, liver, and kidneys120.  According to several authors, this ‘bleeding’ 
or silicone diffusion may be associated with systemic complications and symptoms 





the strategies mentioned above do not ensure long-term volume restoration and result 
in low patient satisfaction due to the absence of long-term graft retention and 
aesthetic restoration, necessitating a more robust strategy to repair soft tissue defects. 
 
2.2 Common Scaffold Fabrication Methods Utilized in Soft Tissue Engineering 
Soft tissue engineering has emerged as an alternative for tissue transplantation 
with the primary goal of providing a clinically relevant substitute.  By recapitulating 
the normal tissue development process, soft tissue scaffolds and their subsequent 
implantation represent a strategy to restore, maintain, and improve tissue function.  
The scaffold provides the necessary environment and support for cells to attach, 
proliferate, and maintain their differentiated function and subsequent regeneration of 
new tissues.  Ideally, a scaffold should have the following characteristics124: (1) 3D 
highly porous structure with an interconnected pore network to facilitate cell/tissue 
growth and diffusion of nutrients, metabolic waste, and paracrine factors; (2) 
biodegradable or bioresorbable features with controllable degradation and resorption 
rates to match cell/tissue growth in vitro and in vivo; (3) suitable surface chemistry 
for cell attachment, proliferation, and differentiation; (4) mechanical properties to 
match those of the tissues at the site of implantation; and (5) easy processability to 
form a variety of shapes and sizes.   
 
Biomaterials are used to develop scaffolds and provide important biological signals 
for cells to organize and restore structure and function to damaged tissues.  The 





growth factors and surface chemistry) and biophysical (e.g. fibrous structure, 
hydrophilicity, and stiffness) cues to effectively regulate cellular behaviors such as 
attachment, migration, proliferation, and differentiation 125.  Biomaterials can, at the 
same time, be used to supply nutrients, drugs, and bioactive factors that direct specific 
tissue growth.  Accordingly, these materials should be non-toxic and ideally possess 
mechanical and engineering properties suitable for its intended application.  The 
following sections describe some key developments regarding scaffold fabrication 
and the common materials used in soft tissue engineering. 
 
2.2.1 Conventional Porogen Leaching 
The formation of a porous structure is the main goal of scaffold fabrication. 
Most methods for fabricating porous scaffolds, including particulate leaching, freeze 
drying, gas infusion, and phase separation, rely on casting the scaffold material within 
molds and incorporating internal additives to create a heterogeneous distribution of 
pores.  The porous nature of these structures can be developed by introducing solid 
particulates or gaseous microbubbles as the scaffold material solidifies; once 
removed, the end result is a delicate, interconnected network of pores sprinkled 
within the internal regions of the scaffold126.  Although these techniques are relatively 
simple for developing a three-dimensional structure, they are limited by uncontrolled 
pore size and connectivity, poor mechanical strength, and residual solvent/porogens 
127.  Hydrocarbon templating, a combinatorial process of polymer mixtures, 
compression, and vacuum treatment, is a fabrication method with enhanced control 





a disadvantage for biological applications of the porous foam as this cytotoxic reagent 
is difficult to remove completely from the scaffold.  Alginate, a polysaccharide 
derived from the cell wall of brown seaweed, is a widely utilized biomaterial used in 
this fabrication technique due to its biocompatibility, mild and physical gelation 
process, chemical and physical cross-linking abilities, non-thrombogenic nature, and 
the resemblance of its hydrogel matrix texture to that of the native extracellular 
matrix.  In a study using conventional porogen leaching to mimic the heterogeneity of 
the native adipose tissue, a potential to achieve a foamy structure using this type of 
approach was demonstrated with alginate, but with concerns on the long-term 
maintenance of the scaffold geometric properties129.  
 
2.2.2 Hydrogel Casting 
Various synthetic and natural polymers can be dissolved and chemically 
crosslinked in solution to form three-dimensional hydrogel networks.  Poly(ethylene 
glycol)130, poly(N-isopropylacrylamide)131, poly(vinyl alcohol)132, and 
poly(acrylates)133 are synthetic examples of these materials, while gelatin134, silk 
fibroin135,136, fibrin137–141, and hyaluronic acid142,143 are those of natural materials.  
Hydrogels are commonly used in soft tissue engineering as accessible casting 
methods render physiologically relevant mechanical properties and hydrated gels 
capable of encapsulating cells or bioactive molecules144,145.  Photopolymerizable 
functional groups are needed for the creation of these gels so that the matrix remains 





of the hydrogel material determines its particular crosslinking capabilities;  some are 
crosslinked using visible or ultraviolet light when certain crosslinking agents are 
present146, while others may be crosslinked through heat, ionic, or covalent bonding.  
The mechanical properties, mass transport, and degradation characteristics are 
defined by both the polymer composition and crosslinking density and can be further 
fine-tuned to create hydrogels for a vast range of soft tissue applications147.  
Furthermore, hydrogels can be chemically modified to improve the adhesion and 
proliferation of cells within or directly on gel matrices through the inclusion of 
adhesion peptides.  One major setback of most degradable hydrogel materials is their 
limited mechanical strength.  Degradable hydrogels have a tendency to fracture when 
subjected to compressive loads due to their brittle and swollen nature, which can 
result in a structural collapse and ultimate scaffold failure144.  This soft matrix is 
unsuitable for most soft tissue defects, as these areas of the body (such as breasts) do 
experience regular compressive forces.  
 
2.2.3 Synthetic Fiber Electrospinning 
Electrospinning synthetic polymers is a popular method used to generate a 
fibrous scaffold containing fibers ranging from several nanometers to several 
micrometers in diameter.  The woven fiber matrix that results from this fabrication 
technique greatly mimics the extracellular matrix of collagen fibrils visualized in 
tendons and ligaments148, a major tissue composition found in soft tissue engineering.  
Deposition speed and charge of the synthetic material can dictate the strand diameter 





are advantageous due to their high surface-to-volume ratio and interconnected porous 
architecture, which can help cells easily penetrate to the internal regions of the 
scaffold.  Saturated aliphatic polyesters, such as polylactide(PLA), 
polyglycolide(PGA), and poly(caprolactone) (PCL), are the most common used 
biodegradable synthetic polymers for electrospun scaffolds150–152.  The chemical 
properties of these polymers allow hydrolytic degradation, where de-esterification 
occurs as the main chain ester bonds are exposed to water.  The rate and extent of 
degradation depends on the polymer’s molecular weight, structure, and composition.   
For example, PCL and PLA have been previously electrospun into aligned fibrous 
scaffolds that have been shown to promote neural differentiation of human MSCs and 
the elongation of the formed neurites when compared to conventional flat casting film 
culture practice153154.  The setback of this fabrication technique is that it is difficult to 
control the distance between fibers, and the resulting scaffold is a dry, stiff matrix that 
greatly differs from the surrounding natural tissue.    
 
2.2.4 Additive Manufacturing 
3D printing is a modern fabrication method where digital data of a three-
dimensional structure is converted into a physical object.  The ability to scan existing 
host tissue via computed tomography (CAT) and replicate the exact dimensions of 
that target greatly appeals to soft tissue reconstruction, where there is a high instance 
of uniquely size defects resulting from either trauma or the resection of tumors and 
congenital deformities155.  In contrast to traditional fabrication methods (involving 





layer-by-layer fashion.  Generally, a structure is first visualized digitally with the help 
of computer-aided software (e.g. SolidWorks and CreoParametric) and later sliced 
into individual layers by the specific printer software providing a specific set of 
instructions that control printer movements and functionality.  Three major 
approaches for 3D bioprinting soft tissues currently exist: inkjet printing, extrusion 
printing, and stereolithography.  The chosen fabrication method will vary in terms of 
materials used, the construct design parameters, and the time needed for the creation 
of the desired part.  Below is a brief description of each type printing method, as well 
as its positives and pitfalls. 
 
Inkjet Printing.  Much like how a traditional printer utilizes ink cartridges to deliver 
droplets to paper to create documents, inkjet bioprinters can deliver biomaterials 
and/or cells in controlled volumes.  These printers have the finest resolution in bioink 
deposition (50 µm- 1 mm) and the highest printing speeds (15-25 kHz)156.  Droplets 
are synthesized through either thermal or mechanical means, a mechanism that 
enables a high spatial resolution; however, the stresses produced through these means 
can perturb cells during the printing process.  Instant heat exposure and shear stress 
can also induce cell damage.  Since ink for this printer must be fluid so that individual 
droplets can form, this type of technology has one of the highest selection of 
materials available.  However, the size of the printed object is significantly small, and 
the cell density of the bioink can be limited157.  As such, inkjet printing is best for 2D 






Stereolithography and Digital Light Projection.  Stereolithography (SLA) and Digital 
light projection (DLP) are two forms of light-based additive manufacturing processes.  
In the SLA process, an ultraviolet laser located directly below the printing platform is 
instructed to focus at specific points in space to locally polymerize the biomaterial.  A 
3D object of any desired shape can be made by creating a specific light path for each 
2D slice over the height of the printing volume158,159.  The DLP process is similar to 
that of SLA, except the light source is projected as a 2D light mask across the resin 
bath.  The advantage of SLA and DLP includes high accuracy and precision during 
the printing process.  Since the optical point of the laser/projector can be finely 
controlled, the resulting resolution is significantly high and small geometric parts can 
be easily fabricated.  However, there are several pitfalls with this fabrication 
technique.  Both SLA and DLP printing processes have low material versatility.  
Photo-curable acrylate resins and epoxies, the original polymers that helped define 
these methods, continue to be the most common materials for this fabrication process.  
In addition, only one photopolymerizable material can be used during the printing 
process, as the print platform is completely submerged into a single polymer vat 
throughout the print, and un-crosslinked material pose a health hazard to users as it 
contains radical photoinitiators.  Low cell viability is also common when hydrogel 
polymeric solutions are used as excessive exposure to UV/visible light during a 
lengthy print time tends to kill the cells seeded within the polymer vat.    
 
Extrusion 3D Printing.  Both Fused Filament Fabrication (FFF) and Pneumatic 





the printer head extrudes continuous filaments of shear-thinning, thixotropic material 
(either synthetic filaments or hydrogels containing biomacromolecules or cells) 
through a nozzle (under step motor driven mechanical forces or pneumatic pressure).  
Acellular scaffolds and cell-laden hydrogel constructs can be fabricated layer-by-
layer as the print head moves in 2 dimensions (x and y) to deposit matrix in one 
horizontal plane at a time.  Some advantages of FFF and PD include high material 
versatility, multi-material printing, and low cost when compared to other 3D printing 
methodologies.  Examples of inks compatible with this deposition method include 
hydrolytic synthetic polymers, gelatin, fibrin, alginate, hyaluronic acid mixtures, and 
silicate nanoplatelet mixtures160.  The combination of multiple materials via various 
extruders or printing cartridges allows for facile engineering of chemically and 
structurally complex tissues.  Compared to resin-based methodologies such as SLA 
and DLP, material is better conserved during this fabrication technique as a polymer 
vat containing excess material is not necessary.  Though extrusion printing is an 
efficient and low-cost method for fabricating cell encapsulated constructs, the 
printing resolution is limited by the print head’s diameter and by the viscosity of the 
biomaterial161.  Shear-thinning biomaterials, in regard to strain rate or temperature-
dependent properties, are also limited as this fabrication process requires the material 
to maintain strand shape.  Despite these limitations, this is our fabrication method of 
choice as previous work indicates that pneumatic driven extrusion 3D printing holds 
promise for the fabrication of soft tissue engineering constructs.  In the following 
section we will dive deeper into some of the difficulties and considerations required 





2.3 Current Setbacks in Extrusion Printing for Soft Tissue Engineering 
Though extrusion-based 3D printing is highly beneficial when fabricating TE 
scaffolds, there are material concerns when this technology is applied to soft tissue 
engineering.  Bioink, the matrix material used for tissue printing, should provide 
suitable cues and signals for cellular function and tissue formation.  Various 
naturally-derived extracellular matrix components, such as collagen/gelatin162,163, 
alginate164,165, fibrin166, and hyaluronic acid167, have been well investigated in terms 
of printability; yet, their application to soft tissue regeneration result in failure due 
these weak materials rapid remodeling in vivo and subsequent loss in structural 
features.  Melt extrusion of synthetic polymers such as polycaprolactone168, 
poly(D,L)-lactide169, and copolymers such as poly(L-lactide-co-caprolactone)170 have 
also been investigated, but their incorporation to soft tissue regeneration also renders 
unsuccessful due to similar hydrolytic degradability of these materials and the 
mismatch in mechanical properties between the stiff printed constructs and the native 
soft tissue.   
 
In contrast to rigid melt-extruded polymers, synthetic hydrogels are three-
dimensional, hydrophilic polymer networks that hold exciting promise in the material 
choice for soft tissue regeneration.  Since the application of 3D printing technology to 
the bioengineering field has been recent, few papers report the invention of an 
extrudable synthetic hydrogel ink for pneumatic deposition printing practices.  In fact, 
a mere handful of groups171–174 have been able to produce extrudable hydrogels 





use biomedical applications.  Previously, PEG has been used in drug delivery175,176, 
where the ability to swell can be utilized to deliver molecules of various sizes and 
chemical structure, biosensing177, where degradation of copolymerized PEG with 
enzymatically degradable peptide linkages signals the presence of an antigen, and in 
tissue engineering178, where casted hydrogels provide an environment for 
proliferating cells.  In all of these cases, however, the PEG monomers were dissolved 
in an aqueous solution containing photoinitiators and further casted into a gel when 
exposed to UV light.  These PEG solutions act as Newtonian fluids that are unable to 
hold strand shape and thus unable to be effectively printed via extrusion.   
 
While PEG hydrogels are inert and exhibit low toxicity, they are not biodegradable179.  
This allows for these gels to retain permanent shape when implanted in vivo, but these 
constructs display poor host integration due to the synthetic material’s lack in 
bioactive moieties.  PEG chemistry can easily be tailored to allow for cell infiltration, 
such as copolymerization techniques of poly(alpha-hydroxy esters), poly(lactic acid), 
or peptides, yet adding these functionalities renders a similar solubilized fate as the 
other materials mentioned above.  Therefore, the first goal of this work was to 
establish a hybrid printing technique that capitalizes on the strengths of both natural 
and synthetic hydrogels to create printed structures containing tunable mechanical, 








Chapter 3: Hybrid 3D Printing of Synthetic and Cell-Laden 
Bioinks for Shape Retaining Soft Tissue Grafts2  
 
3.1 Introduction 
Despite recent advances in clinical procedures, the repair of soft tissue 
remains a reconstructive challenge.  Current technologies such as synthetic implants 
and dermal flap autografting result in inefficient shape retention and unpredictable 
aesthetic outcomes.  Extrusion-based 3D printing offers an efficient tool for accurate 
fabrication of biomaterial scaffolds with tunable properties180, and though this 
fabrication process is highly beneficial, there are similar material concerns when this 
technology is applied to soft tissue engineering.  As discussed in the previous chapter, 
natural materials undergo rapid remodeling and collapse in vivo, while synthetic 
polymers lack surface ligands for cell attachment and have a mechanical mismatch 
with the native soft tissue.  Although numerous advances in bioink formulations have 
been made, no ink is singularly capable of mimicking soft tissue with long-term shape 
and size retention, mechanical stability, and host integration. 
 
To address these shortcomings, we have developed a dynamic hybrid printing 
approach that capitalizes on the strengths of both nondegradable and biodegradable 
 
2 Adapted from: Van Belleghem S, Torres Jr L, Santoro M, Mahadik B, Kofinas, P, and Fisher, JP, 
“Hybrid 3D Printing of Synthetic and Cell-Laden Bioinks for Shape Retaining Soft Tissue Grafts”. 





hydrogels to create biomimetic constructs with long-term shape and volume retention 
(Figure 3.1).  Our design incorporates two inks: a double network (DN) of 
poly(ethylene) glycol (PEG) covalently linked with naturally derived and physically 
crosslinked alginate, and a biodegradable cell-laden bioink of gelatin methacrylate 
(GelMA).  The DN ink provides robust physical support necessary to retain long-term 
graft volume and architecture, while the degradable GelMA bioink provides the 
biological environment necessary to stimulate tissue regeneration (Figure 3.1A).  This 
printing method results in the precise placement of hydrogel strands that functionally 
complement each other and enables for the construction of complex geometries 
(Figure 3.1B).  With this 3D bioprinting strategy, complex geometries with robust 
internal structures can be easily modulated by varying the print ratio of non-
degradable to sacrificial strands.  Results display various swelling characteristics and 
mechanical properties can be obtained by tuning the print ratio of DN:GelMA inks.  
The versatility of this hybrid printing fabrication platform can inspire the design of 
future multi-material regenerative implants. 
 
With the advancement of tissue engineering, numerous medical products and devices 
have been developed to address unmet clinical needs. Although preclinical research is 
important in developing new technologies, their application at the clinical stage must 
satisfy regulatory oversight at the government level.  The application of these 
regulations is highly regimented and well established for drug therapies; however, it 
becomes more challenging for multicomponent tissue-engineering products and 3D 





thoroughly examined181.   And while many different materials have been assessed for 
3D printing, due to the lack of systematic research on the printing procedures and 
methods for properly evaluating accuracy in part fabrication, the reported fabrication 
methods are highly specific and case-dependent.  Our present study additionally 
develops an advanced evaluation process incorporating scanned point cloud entities 
of printed scaffolds and computational comparisons between scaffold surfaces to 
investigate the correlation between printing parameters and the resulting shape 
aesthetics of complex bioprinted scaffolds.  This new shape analysis technique can 
expand the available toolbox for assessing scaffold aesthetic properties and serve as a 
potential systematic procedure for evaluating 3D printed regenerative implants.   
 
3.2 Materials and Methods 
Synthesis of 4-Arm PEG Norbornene 
4-Arm PEG Norbornene was synthesized as previously reported.182  Briefly, 5-
norbornene 2-carboxylic acid was added at 10X access (basis: PEG hydroxyl groups), 
with 5X excess dicyclohexylcarbodiimide in dichloromethane, and the solution was 
stirred for 30 minutes at room temperature.  Separately, 4-arm PEG (MW: 5 kDa, 
10kDa, and 20kDa, JenKem) was dissolved in dichloromethane, with 5X pyridine and 
0.5X 4-(dimethylamino)pyridine (DMAP) and then added to the DCC/norbornene 
solution.  The reaction mixture was stirred overnight at room temperature under 
argon.  The product was precipitated into ice-cold ethyl ether 3 times to rid the 
solution from the excess toxic reactants.  The polymer was then left for 48 h in a 





Double Network Ink 
 The double network ink was synthesized by first dissolving 5% (w/v) 4-arm PEG 
Norbornene and 5% (wv-1) 4-arm PEG Thiol in deionized water.  Lithium phenyl-
2,4,6-trimethylbenzoylphosphinate (LAP, Sigma Aldrich) with a 0.2% w/v ratio and 
alginate powder (Sigma) with a w/v ratio varying from 1-5% (derived from brown 
algae, Sigma) was added and thoroughly mixed.  The ideal amount of alginate used 
for thickening the PEG solution was then tested by systematically extruding the 
various formulations through the printer cartridge.  
 
Swelling of DN Ink 
For each ink formulation (5K, 10K, and 20K), solid discs with a 5 mm diameter and 2 
mm thickness were casted using previously printed molds.  Disc dimensions, wet/dry 
weight, and bright field images of each sample were taken before and after a 24 h 
incubation at 37°C.  Percent increase measurements (in mass, thickness, and 
diameter) were calculated by dividing the difference of swollen vs. unswollen 
measurements by the original unswollen value.  Mass swelling ratio was similarly 
calculated by dividing the difference of swollen vs. the lyophilized dry weight by the 
lyophilized dry weight value.  
 
GelMA Bioink  
Type A porcine skin gelatin (300 bloom; Sigma-Aldrich) was dissolved at 10% (w/v) 
into phosphate-buffered saline (PBS; Thermo Fisher Scientific) at 50°C for 20 min.  





solution under vigorous stirring for 1 h (0.6g MA per gram of gelatin).  The mixture 
was diluted with PBS to stop the reaction and centrifuged at 2000g for 2 min.  The 
supernatant was collected and dialyzed (10 kDa molecular weight cutoff; Thermo 
Fisher Scientific) to remove the excess salts and acids.  The dialyzed GelMA was 
then lyophilized and stored at minus 80°C. For printing, lyophilized  GelMA was 
dissolved at 7% (wv-1) in phosphate buffered solution at 50°C for 20 mins.  Irgacure 
2959 (0.2% wv-1, BASF) was added at 50°C for 15 min.   
 
Hybrid Scaffold Fabrication 
Complex architectures consisting of human nose, ear, and thyroid cartilage (adopted 
from 3D scans, GrabCAD) were printed in a 1-1 DN-GelMA pattern. All model 
scaffolds were sliced into layers with a slicing thickness equal to 80% (0.32 mm) of 
the needle size (0.4mm) before printing.  Each printed layer was exposed to UV light 
(5 mW cm-2 intensity) for 5 s, and the final print was placed in a UV box (5 mW cm-
2) and exposed further for 6 min.  For the remaining assays, 3D cylinder models with 
5 mm diameter and 2 mm thickness were designed in SolidWorks (Waltham, MA).  
For the cytotoxicity assay (1-1 pattern), prints were immediately transferred to 6-well 
tissue culture plates and submerged in media, with media changes every 2 days for 2 
weeks. Cylindrical scaffolds were printed with varying ratios of bioinks (DN:GelMA- 
1:0, 2:1, 1:1, 1:2, and 1:3)  for mechanical testing. Half of the produced scaffolds 
were exposed to collagenase IV (500 Units mL-1, Worthington Biochemical 






Mechanical Testing of Hybrid Scaffolds  
Compression testing was performed on a Dynamic Mechanical Analyzer (DMA 
Q800, TA Instruments) with a strain sweep (0-15%) and load 0.01N at 1Hz 
frequency.  Elastic modulus for each sample was calculated by determining the slope 
of the linear region of the stress-strain curve (strain region of 3-5%).  Fracture 
strength was recorded (force at which the hydrogel plastically yields) as well as 
toughness (area under stress-strain curve).  
 
Point Cloud Generation  
The ROMER Absolute Arm (Hexagon) was used to generate point clouds containing 
high geometric detail of the scanned surface.  Scaffolds were sprayed with water 
soluble paint prior to scanning for greater ease in detecting surfaces.  The noses were 
sequentially scanned at multiple angles and the surfaces were selected using the 
software’s editing brush tool.  After the total region of interest was created, a volume 
was generated and exported as a stereolithography (STL) file.   
 
Surface Alignment: STL files of the same sample (both pre and post digestion scans) 
were imported into the open-source software MeshLab (Visual Computing Lab- ISTI 
CNR). With this software, the alignment tool and its ‘point-based alignment’ were 
used by selecting four possible points along the base face of each model: the first at 
the center tip of the nose bridge, the second 1mm distance left from the central y axis, 
the third 1mm distance right from the central y axis, and the fourth at the bottom edge 





was used for fine superimposition.  This feature is an ICP (iterated closed point) 
algorithm capable of enhancing alignment by finding corresponding points on both 
models to allow for a refined superimposed reposition.  Once both models are 
superimposed, visual comparison of the coincidence in anatomical structures is 
possible.  This final alignment is frozen and exported as a new file, which will keep 
the achieved alignment intact once opened in the second open-source software 
CloudCompare.  
 
Cloud Comparison   
The two repositioned STL meshes for each pattern were uploaded into the 
CloudCompare software and point cloud comparison was performed by selecting the 
pre-digestion mesh as the reference and the postdigestion mesh as the compared 
object.  A color map was generated, which calculated the distance of points in the 
compared cloud to the nearest point in the reference pre-digestion cloud.  For the 
color maps, a yellow color signified coincident points, while an orange-red spectrum 
(positive deviation) or green-blue spectrum (negative deviation) indicated the lack of 
coincidence.  A graph also provided the concentration of points analyzed by its 
distance.  CloudCompare’s Point Picking function allowed distances to be obtained 
along the length, width, and peak height of the scaffolds and the Fit Sphere function 
rendered dependable approximations in the total magnitude in radius of scaffold 
curvature (left nostril, right nostril, and nose tip).  This allowed for distinct 







Statistical Analysis. Data was analyzed using single factor analysis of variance 
(ANOVA) followed by Tukey’s Multiple Comparison Test assuming normal data 
distribution with a confidence of 95% (p<0.05).   
  
3.3 Results and Discussion 
3.3.1 Double Network Support Structure 
To begin, 4-arm thiol-ene PEG hydrogels were chosen due to this system’s 
predictable swelling characteristics, low toxicity, inertness, and resistance to common 
enzymes.183  Because this solution exhibits low viscosity at low monomer 
concentrations, it cannot be loaded into a cartridge and printed alone; this solution is 
not self-supporting for layer-by-layer fabrication and must either be made very 
viscous by increasing PEG content or including a thickener.  Therefore, alginate was 
chosen as a thickener for our PEG ink solution since it has been shown to be an 
effective agent in creating extrudable hydrogels and can provide the opportunity for a 
second physically crosslinked interpenetrating network when subjected to calcium 
ions.184,185  We found that an alginate concentration of 4% (w/v) produced the most 
ideal filament when mixed with a 10% 4-arm PEG solution, and this composition was 








Figure 3.1: Description of printed inks and hybrid scaffold. A) 4-arm PEG 
monomers functionalized with norbornene and thiol end groups react when 
photoinitiator LAP is present within the solution, as alginate ionically crosslinks with 
itself with the presence of calcium ions; GelMA monomers mixed with cells and 
Irgacure 2959 results in a crosslinked cell-encapsulated bioink strand; B) visual 
representation of alternating PEG and GelMA inks in 1-1 pattern to create a hybrid 
scaffold.  Complex architectures can be created using this printing technique, such as 
C) human nose, D) ear, and E) thyroid cartilage (commonly known as Adam’s 








The thiol-ene chemistry provides the added advantages of high crosslinking speed 
when exposed to UV light, a key factor used in our printing process to intermittently 
crosslink layers, and its cytocompatability, as the crosslinking of step-growth thiol-
norbornene hydrogels is not oxygen-inhibited.182,186  The thiol-norbornene reaction 
not only can be initiated several orders of magnitude faster than the classic method of 
random chain-growth photopolymerization, but also results in a more uniformly 
crosslinked gel since each monomer with a defined functionality serves as a single 
crosslinking point.187  The degree of network heterogeneity is also at a minimum 
when compared to random chain-growth polymerization, since chain-polymerized 
gels contain an unfixed number of arms per crosslinking point due to the reaction’s 
random nature of radical propagation and termination.188  Thus, the thiol-ene 
chemistry allows for a greater control when designing the swelling and mechanical 
properties of our ink.  To test our material’s swelling properties, PEG hydrogels 
composed of either 5k, 10k, or 20k Da monomers were first casted into discs to 
characterize the amount of swelling in excess water (Figure 3.2).   Hydrogels 
composed of higher molecular weight monomer experience more swelling when mass 
was held constant as observed in previous studies.  For example, previous literature 
has shown poly(ethylene) glycol hydrogels swell greatly under physiological 
conditions and often become undesirably weak or brittle after swelling, which limits 
their applications.189  Mass swelling ratios are reported in 20–100 range, nearly 
tripling the hydrogel’s originally casted size.187,190  In our experiments, the smallest 
molecular weight monomer (5k) pure polymer network originally had the smallest 





for printing purposes inhibited perfect PEG crosslink formation, which ultimately 
caused the once favorable 5k swelling ratio to dramatically increase (Figure 3.2E).  
While the higher molecular weight inks can be printed, significant hydrogel swelling 
and scaffold disfigurement make these ink formulations suboptimal as an engineered 
soft tissue replacement.  When the alginate thickener was ionically crosslinked with 
calcium ions (after photopolymerization of the thiol-ene network), the swelling was 
significantly reduced due to the restriction of the interpenetrating secondary 
polymeric network.  Though double network chemistry is known to create extremely 
strong hydrogels able to withstand significant stress with minimal distortion, they 
have only been created with cytotoxic materials previously in literature 
(polyacrylamide).191,192  Our choice in alginate as both the ink thickener and the 
secondary polymeric network is cell-friendly and has been dependably used for 3D 
printing practices by others.184,185,193  Overall, alginate physical crosslinking 
prevented swelling by 32 ± 0.2% in the 5k ink, 53 ± 1% in the 10k ink, and 208 ± 
0.1% in the 20k ink (Figure 2D).  The 5k ink swelled the least when alginate ionic 
crosslinking was introduced (mass swelling ratio of 2.4 ± 0.1), with casted disc 
samples experiencing 5 ± 0.2% increase in diameter, 6 ± 3% in thickness, and 23 ± 
1% in mass.  The limited swelling of the 5k ink made it an ideal candidate for soft 
tissue printing, and therefore was further evaluated for cytotoxicity and mechanical 






Figure 3.2: Swelling characteristics. A) Description of ink formulations with 
varying PEG molecular weight monomers where either i) a pure PEG crosslinked 
network, ii) added alginate for thickening purposes, and iii) a double network 
consisting of covalently crosslinked PEG and physically crosslinked alginate was 
formed. Brightfield images revealed that the interpenetrating networks resulted in the 
least visual swelling (red box). B) diameter percent increase, C) thickness percent 





(synthesized with molecular PEG weight 5K, 10K, or 20K Da) processed under 
various conditions (Pure PEG and PEG + Alginate contained no calcium soak, PEG + 
Crosslinked Alginate with calcium soak). n=6 and mean ± standard deviation is 
depicted. Data was analyzed using single factor analysis of variance (ANOVA) 
followed by Tukey’s Multiple Comparison Test assuming normal data distribution 
with a confidence of 95% (p<0.05). 
 
3.3.2 Hybrid Printing 
GelMA is chosen for its resemblance to native extracellular matrix, and offers 
significant advantages such as its ease in printability, UV photopolymerization,  and 
natural cell binding motifs.194–197  It is widely known as a tunable biomaterial whose 
composition (weight percentage) and crosslinking degree (UV exposure, 
photoinitiator concentration, and degree of methacrylation) can be customized to 
match its rate in degradation to the regenerated tissue it is replacing.198,199  By 
strategically co-printing GelMA and the DN inks, our hybrid constructs can be 
tailored in both stiffness and degradation rate by varying the ratio of each ink in the 
print.  Soft tissue engineering requires matching of mechanical properties to the 
native tissue, otherwise detrimental effects to the tissue aesthetics can occur.  The 
compressive moduli, toughness, and fracture strength were characterized for various 
print patterns of DN ink and GelMA bioink (Figure 3.3).  Patterns of DN-GelMA 
varied from 1:0 (no tissue regenerative capacity, control) down to 0:1 (completely 
degradable GelMA, control) (Figure 3.3A).  Since the GelMA network can degrade 
by collagenase, a naturally occurring enzyme in the body, the long-term mechanical 
properties of the composite scaffold are mainly dictated by the presence of the DN 
ink’s two tightly crosslinked, interpenetrating polymeric networks.  Therefore, the 





after exposure to collagenase IV (500 Units/mL) overnight.  Under uniaxial 
compression, the composite hydrogels are elastic within 15% strain with moduli 
scaling a 4-fold variation in stiffness, dependent on DN ink presence- a range 
congruent with the stiffness values of soft tissue (e.g. skeletal muscle (500kPa) to 
adipose (10kPa) compressive moduli values, Figure 3.3B).200–202  Decreasing the 
double network fraction from the highest 1:0 pattern to the lowest 1:3 DN-GelMA 
pattern manifested a 74.5% decline in modulus.  Printing GelMA alone resulted in a 
significantly less stiff scaffold (36.8 ± 15.6 kPa), revealing that the coprint benefits 
from the incorporation of the DN ink for scaffold reinforcement.  Scaffold toughness 
and fracture strength are critical mechanical properties that display the scaffold’s 
ability to maintain shape while under compressive forces during tissue remodeling 
and implant healing.  Both toughness and fracture strength remained high in all 
patterns before exposure to collagenase IV (1517.8-1836.3 kPa, 26.7-28.9 kPa 
respectively).  Post-digestion analysis similarly revealed that toughness and fracture 
strength most closely resembled the dominant matrix of the hybrid’s material 
makeup.  Together, these results show that the hybrid printing strategy can be used to 
produce novel tissue constructs with controllable degradation rates, while 







Figure 3.3: Mechanical testing of various print patterns. A) Visual description of 
the various print patterns used to fabricate hybrid scaffolds. Uniaxial compression 
testing was performed on hybrid disc scaffolds both before and after experiencing 
GelMA digestion via collagenase IV. Mechanical properties, such as B) compressive 
modulus, C) fracture strength, and D) toughness were characterized to ensure hybrid 
scaffolds exhibited similar properties to soft tissue. n=5 and mean ± standard 





followed by Tukey’s Multiple Comparison Test assuming normal data distribution with a 
confidence of 95% (p<0.05). 
3.3.3 Scaffold Aesthetic Properties Mapped with CloudCompare 
In addition to maintaining similar mechanical properties to native soft tissue, 
shape retention is of upmost importance to ensure long-term success of the soft tissue 
reconstruction.  To this end, a model of an adult human nose was designed and scaled 
down to 1/3 of the average physiological size and printed with the hybrid inks 
(Figure 3.4).  Again, the alternating patterns of DN ink to sacrificial GelMA bioink 
were used to print the complex nose shapes, and the scaffolds were 3D scanned with a 
Hexagon ROMER Absolute Arm both before and after digestion to determine 
variations in scaffold surface and shape.  Iconic characteristics of the scaffold (i.e. 
width, length, height, and curvature, Figure 3.4B) were measured from each surface 
scan.  Across all patterns, a high degree of shape retention was observed with the 
highest deviation of 14.9 ± 3.0% change in width, 13.0 ± 2.7% change in length, and 
4.9 ± 3.3% change in height for the 1:3 pattern.  Significant changes in scaffold 
curvature was only displayed in the 1:2 and 1:3 print patterns by 15.0 ± 4.8% and 
23.3 ± 8.3% respectively when compared to pre-digestive values.  As the GelMA 
content increased, the peak height of the scaffold decreased post digestion, which 







Figure 3.4: Complex scaffold shape retention. A) Noses were printed in various 
patterns of double network ink and GelMA and further subjected to collagenase IV 
digestion (Print patterns PEG:GelMA of 1:0, 2:1, 1:1, 1:2, and 1:3). B) Scaffold 
dimensions were recorded and compared to its original fabricated form, specifically 
C) width, length, and peak height.  D) Magnitude of curvature was also calculated 





Data was analyzed using single factor analysis of variance (ANOVA) followed by 
Tukey’s Multiple Comparison Test assuming normal data distribution with a 
confidence of 95% (p<0.05). 
 
The development of this new printing technique also demands the development of a 
new approach to qualitatively assess scaffold shape maintenance.  The application of 
finite element mesh analysis via a 3D evaluation software named CloudCompare 
allows both quantitative and qualitative characterization of shape deviations with such 
high detail that has not yet been visualized in the Tissue Engineering field.  Thus, 
heat map analysis was performed where the surface mesh data sets were 
superimposed on each other for pairwise comparisons (MeshLab), and deviations 
between the pre- and post-digested scans were determined using CloudCompare 
(Figure 3.5).  Detailed methods regarding analysis of the scaffold design using the 
CloudCompare software can be found in the Supplemental Methods section. This data 
holistically shows the DN ink’s ability to dictate scaffold shape during degradative 
remodeling processes.  Color maps illustrated a spectrum of yellow (indicating the 
standards of a perfect match), red and blue color (both indicating the lack of 
coincidence) depending on the DN-GelMA pattern used.  The distribution of the 
points in relation to the distance from the referenced pre-digested surface can be 
visualized on the right side of these maps.  Together, the color maps and graphic data 
displayed in Figure 3.5 show a gradient in shape maintenance depending on the 
pattern used during scaffold fabrication.  In agreement with the above-mentioned 
results, the control pattern 1:0 DN-GelMA displayed the best ability to maintain the 
complex shape of the nose post exposure to collagenase IV, as this scaffold did not 





Figure 3.3, as an increase in modulus is predicted to be from this pattern’s slight 
swelling.  Patterns 2:1 and 1:1 similarly swelled; this is hypothesized to have 
occurred once the constricting GelMA strands dissolved post collagenase IV 
digestion and PEG strands were able to relax and swell.  Pattern 1:2 displayed 
adequate ability in preserving the nose shape when compared to its original printed 
structure, with <1 mm deviation.  Lastly, pattern 1:3 showed the least in ability to 






Figure 3.5: Color maps displaying point cloud comparisons. Hybrid nose prints 
were 3D scanned with a Hexagon Romer Absolute Arm both before and after GelMA 
digestion, such that finite element meshes could be produced and compared.  Color 
maps display deviations of the digested scaffold to its original form, where red/orange 
designate positive deviations (expansion) and green/blue designate negative 





percentage of mesh points that deviated from their initial positions. Scale bar displays 
8 mm.  
 
Taken together, these results indicate that the double network hydrogel can have a 
gradient effect on dictating scaffold shape during degradative remodeling processes, 
allowing the ability to tailor each fabricated scaffold to its intended application.  
However, overall scaffold shape is maintained for all patterns examined.  
Consequently, an effective degree of the non-degradable DN ink can be chosen to tailor 
the desired mechanical properties of the scaffold, such as delicate fat adipose tissues, 
or stiffer muscular tissues, with promising long-term results.  
 
3.5 Conclusion 
We have developed a 3D printing strategy for soft tissue engineering which 
involves a hybrid scaffold composed of sacrificial layers that allows for tissue 
integration and a skeletal network that maintains mechanical and shape integrity.  The 
novelty of this paper lies in the versatile and cell-friendly 3D printing platform that 
we have devised, and the revolutionary application of mesh analysis for assessing 
scaffold aesthetic properties for soft tissue engineering.  We have successfully applied 
these strategies to commonly-used hydrogels such as GelMA, PEG-based, and 
alginate materials utilizing a process of multi-material printing that can be readily 
accessed by the 3D printing and biomedical community.  DN-GelMA printing 
patterns used to fabricate complex scaffolds highly dictate both the composite’s 
mechanical properties and ability to maintain shape post degradation processes. 
Cytotoxicity characterization of the hybrid print revealed high proliferation and cell 





biomimetic hydrogel graft consisting of both degradable and non-degradable parts 
that harmoniously coexist to promote tissue integration while maintaining its original 
printed structure.   
 
To our best knowledge, there are no previous reports on the creation of volume-
stable, mechanically relevant, biocompatible soft tissue grafts fabricated with neither 
single nor multi-material printing.  Overall, a modular and biocompatible ink 
formulation was developed that can be used to fill soft tissue defects and integrate 
with the surrounding environment while providing long term mechanical integrity and 





Chapter 4:  Orchestrated Structural and Bioactive Matrices for 
Engineering a Nipple-Areola Construct 
 
4.1 Introduction 
As discussed in Chapter 2, soft tissue engineering fabrication and culture 
strategies represent a promising and underexplored avenue for nipple reconstruction.  
Both nipple and soft tissue types characteristically exhibit delicate tactile properties 
and defined aesthetic features.  Current SFS techniques to restore the nipple are 
inadequate, as these procedures are associated with high rates of infection, 
multidirectional scarring, and severe nipple flattening43,203.  More importantly, this 
clinical practice is insufficient for the psychological health needs of breast cancer 
survivors as it necessitates repeated intervention due to projection loss.  Accordingly, 
nipple reconstruction remains as an unresolved clinical challenge and can benefit 
from a reimagined, tissue regenerative approach. 
 
One of the challenges that accompanies the reconstruction of this tissue type is 
accurately capturing the relevant size and tactile properties of the nipple.  Various 
attempts to enhance nipple projection have been previously documented in literature, 
such as autologous fat84,203, cartilage80,103,204,205, bone92, contralateral nipple86,206, 
rolled dermal grafts38,207, and synthetic silicone implants96, but these methods have 
not been regularly adopted in clinical reconstructive practice due to negative patient 





enhance the projection for extended periods of time, dissatisfaction remains among 
patients due to the stiff sensation caused by the foreign material.  Autologous fat and 
cartilage grafting report complications of infection, seroma, and fat necrosis, while 
allogeneic and synthetic materials have similar complications along with additional 
risks of exposure (implant perforation through the skin) and over projection.  
Multidirectional scarring is also an end result in these procedures, as complicated 
dermal flaps are still necessary to suture the addition in place.  A method that 
produces a more natural stiffness, regular projection, and minimal scarring would 
increase patient satisfaction. 
 
Our present study seeks to develop a tissue engineered dermal scaffold that promotes 
the formation of a lasting nipple-areola complex for mastectomy patients.  Previous 
work on a dual hybrid printing technique of synthetic and cell laden bioinks has 
offered a conceptual method to fabricate shape-retaining soft tissue scaffolds with 
robust mechanical properties.  Our current study incorporates entangled 
methylcellulose (MC) and PEG networks as the synthetic component of the scaffold 
to provide strength and resistance to projection degradation, while GelMA seeded 
with primary human dermal fibroblasts acts as the natural component to aid in dermal 
regrowth.  To this end, our first objective was to fine-tune the MC-PEG bioink to 
obtain a hybrid scaffold that mirrors the mechanical properties of nipple tissue.  Our 
second objective was to evaluate the fibroblastic contraction experienced during an 
extended period of in vitro culture and to investigate which printing parameters result 





of our hybrid 3D printed scaffolds to provide accurate physical cues for nipple-areola 
reconstruction and inspires potential for in vivo implantation.  
 
4.2 Materials and Methods 
 
MC-PEG Double Network Ink 
Our previous double network ink was modified with the substitution of alginate with 
methylcellulose.  It was synthesized by first dissolving 15% (w/v) methylcellulose 
dehydrated powder with 10% (w/v) four-arm PEG thiol and 10% (w/v) four-arm PEG 
norbornene in deionized water.  Lithium phenyl-2,4,6- trimethylbenzoylphophinate 
(LAP, Sigma-Aldrich) with a 0.2% (w/v) ratio was added and thoroughly mixed 
under 80°C.  The ideal amount of methylcellulose was tested with systematic 
extrusion through a printer cartridge, and further evaluated in its swelling properties.  
 
GelMA Bioink 
Similarly, as before, GelMA was synthesized via dropwise addition of methacrylic 
anhydride (MA; Sigma-Aldrich) to a Type A porcine skin gelatin solution dissolved 
at 10% (w/v) in phosphate-buffered solution (PBS: Thermo Fisher Scientific).  The 
mixture was diluted with PBS to stop the reaction and centrifuged at 2000g for 2 min.  
The supernatant was collected and dialyzed (10 kDa molecular weight cutoff; Thermo 
Fisher Scientific) to remove the excess salts and acids.  The dialyzed GelMA was 
then lyophilized and stored in -80°C.  For printing, lyophilized GelMA was dissolved 





GelMA solution at a concentration of 0.1% (w/v) at 50°C for 15 min, and later 
sterifiltered with a 0.4µm filter.  Primary adult, normal human dermal fibroblasts 
(Passage 3, Lonza) were then added at a concentration of 2x106 cells/mL (for cell 
viability assay) or 10x106 cells/mL (for the shape retention assay) and were 
homogenously mixed throughout the solution.  The prepolymer solution was then 
loaded into a sterile syringe barrel and allowed to equilibrate for 30 min at 23°C.  
  
Hybrid Scaffold Fabrication 
Physiologically relevant human-shaped nipple areola constructs were printed with 
various print patterns (as explained in Chapter 3, PEG:GelMA- 1:0, 1:1, 1:2, 1:3, 
0:1).  All model scaffolds were sliced into layers with a slicing thickness equal to 
80% (0.32 mm) of the needle size (0.4 mm) before printing).  Each printed layer was 
exposed to UV light (5 mW/cm2) for 5 s, and the final print was placed in a UV box 
(5 mW/cm2) and exposed for 3 more min.  For the both the cell viability and shape 
retention assays, the hybrid nipple-areola prints were immediately transferred into 6-
well tissue culture plates and were fully submerged in media, with media changes 
every 2 d for 2/3 weeks.  For mechanical testing, half of the produced scaffolds were 
exposed to collagenase IV (500 Units/mL, Worthington Biochemical Corporation) to 
evaluate the synthetic material impact on the composite mechanical properties.  
 
Mechanical Testing 
Compression testing was performed on a Dynamic Mechanical Analyzer (DMA 





frequency.  Elastic modulus for each sample was calculated by determining the slope 
of the linear region of the stress-strain curve (strain region 3-5%).  These compressive 
moduli were compared against fresh pig nipple teat (Tissue Source, Lafayette) for a 
close in vivo representation of nipple mechanical properties.  
 
Cell Culture 
Primary Adult, Normal Human Dermal Fibroblasts (Lonza) were cultured as per the 
manufacturer’s specifications with Dermal Fibroblast Growth Medium and Growth 
Factor BulletKit (Lonza).  Prior to printing, cells were passaged using tissue culture 
plates and Trypsin/EDTA, with media changes every 2 days.  Cells were then lifted, 
spun down (500g for 5 min) to create a pellet, and resuspended in GelMA ink.  
 
Cell Viability Assay 
Cell viability was assessed using a Live/Dead assay (Invitrogen) following the 
manufacturer’s protocol.  Briefly, 3D printed hybrid nipple-areola constructs (35 mm 
diameter, 8 mm projection height) were incubated with 4µM calcein AM and 2µM 
ethidium homodimer for 1 h at multiple timepoints (Day 0, Day 14).  Fluorescent 
images (n=3 per sample) were taken using a fluorescence microscope (Nikon) and 
processed using Nikon’s NIS Elements AR Software.  Cell viability was determined 
from the ratio of the number of live cells to the total number of cells.  
 
Point Cloud Generation 





high geometric detail of the nipple-areola surfaces.  Scaffolds were sprayed with 
water soluble paint prior to scanning for greater ease in detecting surfaces.  The 
nipple-areola scaffolds were sequentially scanned at multiple angles and the surfaces 
were selected using the software’s editing brush tool.  After the total region of interest 
was created, a volume was generated and exported as a stereolithography (STL) file.  
 
Surface Alignment  
To maintain sterile in vitro culture conditions for the contracted nipple scaffolds, we 
could not spray/scan the same scaffold twice.  Therefore, we could not compare the 
same scaffold from before/after contraction to visualize the exact scaffold 
deformation.  STL files of all unique samples were imported into the open-source 
software MeshLab (Visual Computing Lab- ISTI CNR) for an averaged comparison 
among projection contraction amongst hybrid scaffold type.  Propagation of error was 
necessary in the quantitative cloud comparisons, which is further discussed in the 
next methods section.  With MeshLab software, the alignment tools (‘point-based 
alignment’ and ‘process tool alignment’) were used by selecting four possible points 
along the base areola for each hybrid model. 
 
Cloud Comparison 
The two repositioned STL meshes for each pattern were uploaded into the 
CloudCompare software and point cloud comparison was performed by selecting the 
precontracted nipple projection as the reference and the contracted nipple projection 





points in the compared cloud to the nearest point in the reference precontracted cloud.  
The color map colors were further modified in this chapter to better visualize the 
contraction of the nipple scaffold.  White color signified coincident points, while a 
red spectrum (positive deviation) or blue spectrum (negative deviation) indicated a 
lack of coincidence.  The accompanying histogram to the right of the colormaps 
provide the concentration of points analyzed by its distance.  CloudCompare’s Point 
Picking function allowed distances to be obtained along the diameter of the nipple 
projection, projection height, and the projection’s radius of curvature.  The Fit Sphere 
function rendered dependable approximations in curvature of the nipple projection.   
 
Since each scaffold could not be directly compared, the error to obtain percent 
difference mean values must be propagated.  To propagate the error, we derive the 
formula from the definition of percent difference: 
 
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 =  ∆𝑉𝑉
𝑉𝑉1
∗ 100 =  𝑉𝑉2−𝑉𝑉1
𝑉𝑉1
∗ 100                    (1) 
 
Both the numerator and denominator of the above equation contain its own 
uncertainties (V2-V1) and (V2).  Equation 3 shows the uncertainty for the numerator, 
while Equation 6 incorporates this uncertainty into the final value of the propagated 
error: 
∆𝑉𝑉 =  𝑉𝑉2 − 𝑉𝑉1  ±  𝛿𝛿∆𝑉𝑉        (2) 







𝑁𝑁 =  ∆𝑉𝑉
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Statistical Analysis 
Data were analyzed using single factor analysis of variance (ANOVA) followed by 
Tukey’s Multiple Comparison Test assuming normal data distribution with a 
confidence of 95% (p< 0.05). 
 
4.3 Results and Discussion 
4.3.1 Synthetic Ink Modification for In Vivo Application 
It is of upmost importance that the materials comprising the nipple-areola 
scaffold are both biologically compatible and mechanically stable in order to produce 
a graft suitable for future in vivo implantation.  In our previous work, the synthetic 
material was defined as a double network of ionically crosslinked alginate and 
covalently crosslinked poly(ethylene) glycol.  Although alginate has been used in 
previous implantation studies, this composition is not the most suitable choice for our 
application, as the alginate network requires a constant replenishment of calcium ions 
to maintain its ionic interactions.  Without these ions, the alginate chains slowly leach 





results in significant swelling of the scaffold (can be visualized in Chapter 3 Figure 
3.2).  To combat this limitation, we modified the synthetic ink by substituting 
methylcellulose (for alginate) as the second self-interacting, interpenetrated network 
with poly(ethylene) glycol.  Methylcellulose (MC), a water-soluble derivative of the 
polysaccharide cellulose, has been FDA-approved for use in medicinal capsules and 
tablet coatings as clinical studies have proven the material to be non-allergenic, non-
toxic, and biocompatible208.  This polymer contains highly methylated glucose zones 
that hydrophobically interact to create a ‘turbid strong gel’, and the gelation of this 
material is solidified through exposures of specific temperatures209,210.  In literature, 
MC has previously been shown to exhibit stable hydrophobic chain interactions 
throughout a large range of pH (3-11)211 and resist enzyme degradation212, two 
critical properties that are necessary for our synthetic material to maintain the 
scaffold’s projection as the biodegradable components of the graft are reconstituted 
by infiltrating inflammatory host cells.  Since the material and biological properties of 
MC greatly align with those envisioned for our scaffold, the first objective of this 
work was to optimize MC concentration to produce a bioink with reproducible 
swelling and extrusion properties. 
 
Because of its unique thermal gelation, methylcellulose is a prime candidate for 
pressure-driven extrusion printing.  We created 3 concentrations of methylcellulose 
(10 w/v%, 15 w/v%, and 20 w/v%) homogenously mixed with a 20% PEG solution 
and evaluated each in terms of its printability and swelling post 24-hour incubation in 





most consistent strand diameter and demonstrated a minimal degree of swelling (16.2 
± 1.3%) and was therefore used for the remainder of the experiments.  The high 
polymer weight percentage (MC and PEG content collectively) in these hydrogels 
allows for a greater degree of crosslinking, as both hydrophobic MC interactions and 
covalent PEG bonds are present, and results in a more densely packed polymer 
network.  Once incorporated in a hybrid print, this helps minimize the swelling of the 






Figure 4.1: Components of the Hybrid Nipple-Areola Implant. Two bioinks 
(GelMA and MC-PEG) are co-printed in various patterns to create a hybrid 
regenerative scaffold.  The GelMA bioink is composed of gelatin methacrylate 
polymers that can be crosslinked via UV light exposure when photoinitiator LAP is 
present.  Fibroblasts can be encapsulated within the GelMA bioink and serve as a 
biodegradable region for host dermal integration.  The MC-PEG synthetic ink is a 
double polymer network composed of methylcellulose autonomously interacting with 






 4.3.2 In Vitro Nipple Implant Functionality  
Physiologically relevant nipple-areola scaffolds were fabricated with 
alternating MC-PEG and GelMA bioinks in various print patterns (similar to the 
methods described in Chapter 3).  According to published reports on the 
morphological characteristics and size of the human nipple-areola complex, a human 
nipple projection varies in 6-10 mm in height, 8-13 mm in projection diameter, and 
30-40 mm in areola diameter79.  Our grafts matched this population size with an 
average projection height of 8.2 ± 0.65 mm, 9.3 ± 0.43 mm projection diameter, and 
areola diameter of 29.2 ± 0.36 mm (Figure 4.2).  By strategically altering the print 
patterns of the two bioinks, various hybrid compositions were analyzed in terms of 
internal cell viability and mechanical properties.  It was equally imperative that we 
fabricated a graft that 1) provided adequate diffusion to support cellular proliferation 
and 2) exhibited a stiffness that mirrors the natural value of nipple tissue to account 
for patient preference.   
 
We first investigated the cell viability in response to the print pattern used to fabricate 
the hybrid scaffold, since the MC-PEG dense polymer network may affect the 
internal diffusion of media.  Across print patterns 1:2 and 1:3, the primary adult 
human dermal fibroblasts (2 million cells/mL concentration) displayed a high and 
acceptable range of viability throughout the entire scaffold, where the quantitative 
results ranged from 78.12 ± 13.06% and 85.25 ± 6.58% for day 1 and 78.35 ± 9.59% 
and 74.98 ± 9.52% for day 14 respectively.  Pattern 1:1 is the only hybrid that shows 





1 that decreases to 57.37 ± 6.67% by day 14.  This may signify that a balance is 
needed between the synthetic and biodegradable components in the scaffold’s design 
to obtain a matrix with favorable diffusivity properties that can support high cell 
viability throughout the graft.  Images taken at higher magnification (20X) revealed 
that the living fibroblasts (positive Calcein AM stain) displayed a healthy 
morphology throughout all hybrid compositions.  Day 1 images portrayed cells with a 
rounded morphology, which is expected due to the cells’ recent encapsulation in 
GelMA and pressure experienced during the printing process.  By day 14, however, 
the average cell spreading area gradually increased.  These results indicate that 1:2 
and 1:3 hybrid scaffold compositions support sufficient media diffusion, as no 
significant difference in cell viability is noted throughout the 2-week in vitro culture.  
 
The compressive modulus of hybrid nipple-areola scaffolds was determined to 
demonstrate that the stiffness of the projection can mimic those values experienced in 
vivo.  The achievable range of modulus for the hybrid scaffold is bound by the 
modulus of the two single component hydrogels: MC-PEG at 152.20 ± 4.07 kPa and 
GelMA at 60.73 ± 7.40 kPa (Figure 4.2D).  No significant difference in stiffness was 
observed between the hybrid prints, and all values aligned with the stiffness of pig 
teat tissue (our closest in vivo prediction) within one order of magnitude.  To 
visualize the influence of the internal PEG structure on scaffold stiffness, we digested 
the GelMA strands by incubating the scaffolds in a collagenase solution for 24 hours 
at 37°C and reassessed the mechanical properties of the scaffolds.  In this scenario, 





example, the 1:1 pattern (50.40 ± 5.75 kPa) is significantly stiffer than both the 1:2 
sample (13.27 ± 4.78 kPa) and the 1:3 sample (11.63 ± 5.16 kPa).  Other groups have 
reported that implants composed of degradable materials have the tendency to 
collapse once implanted in vivo, as the biodegradable materials experience rapid 
degradation during the triggered innate immune response199,213.  This indicates that 
the inclusion of MC-PEG in the hybrid scaffold may improve the incorporation of the 
graft by increasing structural integrity of the implant.  To further investigate the 
nipple projection’s structural integrity, analysis in the shape retention of the hybrid 






Figure 4.2: In Vitro Implant Functionality. Hybrid nipple-areola scaffolds were 3D 
printed using the Envisiontec Bioplotter. A. CAD designs of each hybrid print, 
displaying the deposition of GelMA (pink) and PEG (purple) bioinks. B. 
Representative images of each hybrid print, both before and after collagenase 
digestion, scale bar 10 mm. C. Cell viability visualized via Live/Dead (Calcein AM 
green, live cells; Ethidium Homodimer red, dead cells). D. Uniaxial compression 
testing was performed on hybrid scaffolds both before and after experiencing 
collagenase digestion with respective compressive modulus recorded (n=3, p<0.001). 
E. Fluorescent images (n’=5, over n=3 biological samples) were taken using a 
fluorescent microscope (Nikon) and processed using a configured MATLAB code. 
Cell viability was determined from the ratio of the number of live cells to the total 





(ANOVA) followed by Tukey’s Multiple Comparison Test assuming normal data 
distribution with a confidence of 99.9% (p<0.001). 
4.3.3 Nipple Projection Shape Retention 
Nipple flattening is the most notable pitfall of SFS reconstruction as its 
inevitable occurrence causes detrimental effects to the psychological health of the 
patient (Figure 4.3).  In order to improve upon these clinical outcomes, our hybrid 
implant must be able to maintain projection while subjected to the highest level of 
cellular contractile forces.  To test this phenomenon in vitro, a high concentration of 
primary dermal human fibroblasts (10 million cells/mL) was encapsulated in GelMA 
bioink and printed with MC-PEG into nipple projection scaffolds with various print 
patterns (mimicking Chapter 3- PEG control, 1:1, 1:2, 1:3, GelMA control).  The 
areola was excluded from the scaffold design to help minimize experimental costs 
and print time.   After 3 weeks of submerged culture, the scaffolds were 3D scanned 
with a Hexagon ROMER Absolute Arm, and their surfaces were compared to freshly 
printed nipple projection scaffolds (to maintain sterile culture conditions) via point 
cloud comparisons through CloudCompare.  We have previously documented a shape 
assessment technique that utilizes the 3D evaluation software named CloudCompare 
to perform finite element mesh analysis for both quantitative and qualitative 
characterizations214.  For these color maps, regions that display a white color signified 
coincident points, while a red spectrum (positive deviation) or blue spectrum 
(negative deviation) indicated a lack of coincidence (Figure 4.3B).  The color maps 
mirrored our previous results found in the compressive testing mentioned above, 
where the print patterns containing higher MC-PEG content had a greater retention of 





minimal scaffold swelling and shrinkage, while pattern 1:2 moderate shrinkage of 
<0.5 mm, and patterns 1:3 and 0:1 displayed the highest shrinkage of <1.2 mm.  
There appears to be uniform contraction across the projection diameter, as seen by the 
consistent blue hue displayed in maps 1:3 and 0:1.  Although the hybrid patterns 1:2 
and 1:3 experienced significant lateral contraction, they still were able to retain their 
recognizable and pronounced nipple projection.   
 
Point clouds were also compared quantitatively amongst all pattern types (Figure 
4.4B-D).  CloudCompare’s Point Picking function allowed distances to be obtained 
along the nipple projection height and diameter, and the Fit Sphere function rendered 
dependable approximations in the radius of nipple projection curvature.  The error of 
all quantitative results was propagated since each scaffolded was treated under sterile 
conditions (further description in methods).  Across all patterns, a high degree of 
shape retention was observed with the highest deviation of -11.31 ± 3.42% change in 
projection diameter, -10.29 ± 3.72% change in projection height, and -9.33 ± 1.69% 
change in radius of curvature for the 1:3 hybrid scaffold.  The CloudCompare color 
maps and quantitative comparisons of scaffold measurements between print pattern 
suggest that the internal MC-PEG structure can aid in the shape retention of the 
scaffold’s nipple projection.  Its presence helps prevent both lateral and vertical 
contraction of the nipple, and thus aids in retaining curvature of the scaffold 
geometry.  Without this synthetic component, the projection decreases in radius, 
height, and curvature, as displayed in the 0:1 GelMA control.  Overall, the hybrid 





and shape retention and may serve as an effective strategy for the reconstruction of 
nipple-areola constructs. 
 
Figure 4.3: Nipple Projection Shape Retention while Subjected to Fibroblast 
Contraction. A. Projection flattening is a common occurrence in clinical nipple reconstruction while 
skin flap suturing techniques are used. B. Hybrid scaffolds with nipple geometry were printed with a 
high concentration of primary human dermal fibroblasts (10 million cells/mL) and cultured for 3 weeks 
in vitro under submerged conditions. The scaffolds were then 3D scanned, and their respective point 
clouds were compared. Color maps (center) display deviations of the contracted scaffold to its original 
form. Histograms (left) graphically display the percentage of points that deviated from their initial 











Figure 4.4: Quantitative Comparisons Between Hybrid Scaffold Type. A. 
Scaffold dimensions were recorded and compared to its original fabricated form, 
specifically B projection height, C projection diameter, and D projection curvature.  
Percent differences display a gradual decrease in scaffold shape, as the scaffolds 
experienced contraction over the 3-week in vitro culture. n=3 and mean ± propagated 
error depicted. Data was analyzed using single factor analysis of variance (ANOVA) 
followed by Tukey’s Multiple Comparison Test assuming normal data distribution 











In this work, a robust platform that generated physiologically relevant nipple-
areola complex was presented. We successfully incorporated an enzyme and pH 
resistant polymer, methylcellulose, into an extrudable synthetic ink and fabricated a 
hybrid nipple tissue scaffold with promising results for future in vivo implantation.  
Through fibroblast cell patterning, we found the incorporation of the MC-PEG 
material helped helps prevent both lateral and vertical contraction of the nipple, and 
thus aids in retaining curvature of the scaffold geometry.  Cell viability 
characterization also revealed sufficient dermal cell health after multiple weeks of in 
vitro culture.  Our versatile approach can generate customized, acellular nipple-areola 
regenerative grafts that can be seamlessly incorporated into today’s breast 


















While in vitro development of tissues is the starting point of a tissue-
engineered product, an appropriate in vivo model is crucial to validate the tissues’ 
subsequent function.  There exist many medical, legal, and ethical considerations 
when new biomedical products come to fruition, and thus intense preclinical 
investigations are necessary before the product is available to the masses.  Several 
factors need to be assessed in macroscale once the product is introduced to the host, 
for example, the role of angiogenesis in a newly created tissue, complex host immune 
reactions to the graft that could ignite inflammation and/or rejection, as well as 
functional considerations, such as innervation, rheological graft properties, or the 
effects of surgical interventions215.  The complexity of these factors makes it 
impossible to effectively and holistically evaluate the product in vitro and thus it is 
critical to analyze the outcomes of multiple animal in vivo studies to properly predict 
its success upon human implantation. 
 
For an effective soft tissue engineering strategy, successful integration between the 
tissue-engineered construct and the surrounding natural environment is of paramount 
importance.  A poorly integrated scaffold often leads to impaired functionality within 
a few months216.  True integration can be achieved by designing smart templates 





functional tissue connections.  Scaffold porosity, pore network architecture, and 
surface roughness can drastically affect the diffusion of nutrients and cellular 
migration within the tissue-engineered construct217.  Ideally, scaffold physical cues 
should be engineered to mimic the mechanical properties with its surrounding 
environment without inhibiting necessary host cell infiltration. 
 
Additionally, the host immune response is a factor that greatly influences tissue 
regeneration.  The immune reaction to an implant begins with an acute response to 
the injury and an innate recognition of foreign materials; this reaction continues with 
a subsequent chronic immune response when there is an influx of macrophages and 
the development of an avascular fibrous capsule.  In addition, polymorphonuclear 
neutrophils infiltrate the wound and release reactive oxygen species that not only 
clear cellular debris but can also result in rapid degradation of the biomaterial 
scaffold218.  Monocytes and fibroblasts that are recruited to the injury site also release 
inflammatory cytokines, which can cause secondary damage to the surrounding 
tissue219.  If the reaction is significant, it can lead to total rejection of the implant.   
 
As discussed in Chapter 1, tissue engineering strategies actively pursued to 
reconstruct the nipple-areola include the implantation of autologous tissues (fat, 
cartilage, and bone), decellularized rolled dermal grafts, and silicone implants.  
However, besides the clear mechanical mismatch between these materials and nipple 
tissue, extensive surgical complications such as autologous tissue necrosis, donor site 





active, acellular scaffolds remain an attractive alternative to these current strategies as 
it involves in situ tissue regeneration; by providing an instructive biomaterial matrix, 
the scaffold helps guide cell migration and informs the regeneration process.  To 
enhance nipple reconstruction, an acellular 3D printed scaffold whose matrix recruits 
host dermal cells and relies on the body’s innate regenerative ability could be used to 
better reproduce a well-integrated and stable nipple projection.   
 
To expand upon on the concepts and findings from Chapter 4, this study was 
designed to determine whether the optimized hybrid 3D printed nipple-areola 
scaffolds could properly integrate with host tissue in an in vivo model.  A 
subcutaneous rat model was chosen as it is a well-documented model for the 
evaluation of biomaterial implants220–222.  The hybrid scaffolds were fabricated with 
alternating patterns of MC-PEG and GelMA bioinks (similar to the methods of 
Chapters 3 and 4), implanted into the dorsal subcutaneous regions in Lewis rats, and 
further retrieved after 4 weeks.  Histological analysis was performed on the resected 
tissue to assess the severity of the hosts’ foreign body response to the hybrid materials 
and to identify any possible vascularization surrounding the implant.  To properly 
evaluate the histological responses, five blind scorers utilized a modified ISO 10993-
6 Standard to assess the cellular and tissue characteristics both in and around the 
implant.  In most cases, a mild local foreign body reaction was observed consisting of 
a minimal layer of multinucleated giant-like cells and a moderate infiltration of 
polymorphonuclear neutrophilic-like granulocytes at the implant interface, 





suggests that these hybrid nipple-areola scaffolds can provide a promising solution to 
nipple reconstruction.    
 
5.2 Methods and Materials 
Experimental Design 
We obtained permission from our animal ethics committee to perform the 
experimental protocol as follows.  The main goal of our study was to evaluate the 
cellular and tissue responses to novel hybrid biomaterial implants.  All of the 
recorded metrics could indicate the functionality of the material for a nipple-areola 
specific tissue engineered scaffold.  Hybrid nipple prints with a projection diameter of 
9.0mm, projection height 8.0mm, and areola diameter 20.0mm were implanted under 
the superficial cervical fascia in 10 Lewis strain female rats.  The in vivo analysis is 
critical due to the situational degradation expected from these scaffolds.  As the 
biodegradable materials of the scaffolds degrade, we are interested in investigating 
the cell and surrounding matrix and the remaining synthetic material presence.     
 
Scaffold Fabrication 
3D models of nipple-areola constructs were first designed in SolidWorks (Waltham, 
MA).  The two bionks used during fabrication are 1) 7% (w/v) gelatin methacrylate 
solution dissolved in phosphate buffered solution and 2) an aqueous solution 
containing 15% (w/v) autoclaved methylcellulose, 0.2% (w/v) LAP photoinitiator, 
10% (w/v) four-arm PEG norbornene, and 10% (w/v) four-arm PEG thiol.  All 





sterile tissue culture hood and treated with ethylene oxide for surface sterilization 
prior to implantation.  Scaffolds are programmed to be printed with inner patterns 
(similar to those described in Chapter 3 previously: PEG Control 1:0, hybrid 1:1, 
hybrid 1:2, hybrid 1:3, GelMA control 0:1) under controlled conditions, including 
temperature, pressure, print speed, fiber spacing, and needle size.   
 
Animal Surgery 
Adult female Lewis rats (200g) were sedated for surgery in an induction chamber 
under 5% isoflurane and 2 L/min oxygen.  Anesthetic was maintained with 2% 
isoflurane and 2 L/min oxygen through a nose cone for the duration of the procedure.  
Breathing rate was monitored, and the rats were placed on a water recirculating 
heating pad and distant heat lamp.  For the dorsal implantation, the fur was clipped 
with electric shears.  The exposed skin and surgical site were prepared with 
alternating iodophor antiseptic solution and 70% alcohol washes for 3 cycles, and 
further covered with sterile drapes.  Using strict aseptic techniques, a 20 mm midline 
incision was created over the spine at the scapular level.  The incision was deepened 
with blunt dissection, which allowed for the creation of a subcutaneous pocket.  A 
second, shallow incision was made on the superficial cervical fascia- the primary 
subcutaneous connective tissue that lies between the dermis of the rat’s skin and the 
deep dorsal fascia.  The scaffolds were then placed within this pocket, and tacking 
sutures using 4-0 C-14 reverse cutting resorbable sutures closed the fascial pocket.  
This helped stabilize the nipple implant in position to ultimately enhance host cell 





suturing along the midline incision lines, using the same resorbable suture mentioned 
above.  Wound sites were further cleaned with saline, and the animals were 
transferred to a recover cage (2 animals per cage) warmed with a heating lamp.  
General health and wound checkup were performed daily for 2 weeks, followed by 
weekly checkups until the end of the study (4 weeks).  All animals exhibited 
exceptional pain recovery, active behavior, and healthy weight, and no implant 
exposure occurred.   
 
Histological Analysis 
The rats were euthanized 30 days after the implantation with 10% CO2 chamber for 
10 minutes.  The animals were shaved and a dorsal midline incision was made.  At 
this time, it was recorded that 2 of the 10 rats contained palpable exodus present 
under the wound. Both the scaffold implant and the surrounding subdermal pocket 
tissue were explanted and further fixed with a 4% paraformaldehyde solution for 12 
hours at room temperature.  After this fixation, the tissues were soaked in solutions 
containing a gradual increased concentration of sucrose (10% - 30% w/v) and 
embedded in OCT gel for cryosectioning.   
 
Sample sections underwent Hematoxylin-Eosin (H&E) and Masson’s trichrome 
staining per manufacturer’s protocol.  Histopathological features were scored in a 
blind fashion according to a semi-quantitative scoring system suggested in Annex E 
of International Standards of Organization (ISO 10993-6-2016, which takes into 





inflammatory reaction, and the presence of vascularization.  Five blind scorers 
evaluated a total of 150 images with a modified ISO10994-6 protocol to tailor to the 
available microscope 20X capability.  
 
The extent of fibrosis and neovascularization was further analyzed using a 
histomorphometric approach.  The fibrotic capsule thickness was determined using 
the ‘Freehand’ tool in Image J to manually select the fibrotic tissue layer.  The 
Measurements tool allowed 3 measurements to be obtained across the thickness of the 
fibrotic capsule.  The measurement protocol foresaw taking 18 individual thickness 
measurements per implant analyzed.  The independent measurements were then 
averaged to obtain the mean fibrotic capsule thickness.  Neovascularization was also 
quantified per 20X images by counting the number of blood vessels present in each 
image. All the images were captured using 10X and 20X magnification by light 
microscopy (Nikon).   
 
Statistical Analysis 
The quantitative image results (Figures 5.3 and 5.5) were analyzed using a two-group 
Paired Comparison plot followed by Tukey’s Multiple Comparison Test assuming 






5.3 Results and Discussion 
5.3.1 In Vivo Application of Hybrid 3D Printed Scaffolds 
Proceeding sterile fabrication, five of each hybrid nipple-areola scaffold type 
were randomly implanted in the dorsal subcutaneous regions of Lewis rats (3 
scaffolds per animal) to assess the local biological response to these hybrid materials 
(Figure 5.1A).  The Lewis strain, an inbred type, was particularly used to minimize 
the differences in the initial subcutaneous tissue inflammation grade between each 
animal.  All animals exhibited an exceptional pain recovery, active behavior, and 
healthy weight throughout the 4-week study, yet two of the ten animals displayed 
signs of local infection at the incision site with palpable exodus present.  Since it is 
important to only report results from animals without wound complications, the 
results from one scaffold of each type was eliminated.  Thus, a total of 20 scaffolds 
were processed, cryosectioned, and histologically stained with Hematoxylin & Eosin 
(H&E) and Masson’s Trichrome (MT).  Using a modified scoring system following 
the Standard ISO 10993-6: Biological Evaluation of Medical Devices - Tests for 
Local Effects After Implantation, the following criteria were considered for a semi-
quantitative analysis of the tissue surrounding the implant: inflammatory infiltrate, 
phagocytosis, degradation of the implant, fatty infiltrate, neovascularization, and 
capsule characterization.  Slight modifications were made to the ISO10994-6 to tailor 
the analysis to our nipple-areola scaffold and these changes are highlighted in Table 








Presence of inflammatory cells not being macrophages/histiocytes, near implant 
mainly lymphocytes, plasma cells, and/or polymorphonuclear  granulocytes  
Score  Description  
0 No infiltrate present 
1 
Sparse inflammatory response, one or more small conglomerates of cells 
present, or a few single cells present  
2 
Mild inflammatory response, several small conglomerates of cells 
present, or single cells regularly present  
3 
Moderate inflammatory response, several large conglomerates of cells 
present  
4 
Dense inflammatory response, large confluent areas with inflammatory 
cells present  
 
Phagocytosis 
Presence of macrophages and/or foreign body giant cells engulfing implant or cellular 
debris  
Score  Description  
0 No phagocytotic cells present 
1 Sparse phagocytosis, some cells present with phagocytized material 
2 Mild phagocytosis, several cells and/or groups of cells with phagocytosis  
3 
Moderate phagocytosis, several groups of cells with phagocytosis and/or 
zone of phagocytic cells around implant  
4 
Dense phagocytosis, all material phagocytized either as large fragments 















Presence of cell death zones caused by tissue autolysis 
Score  Description  
0 No necrosis present 
1 
Sparse necrosis, one or more small areas of increased cytoplasmic 
binding of eosinophilic dye 
2 Mild necrosis, several small conglomerate areas of cell death 
3 Moderate necrosis, several large conglomerate areas of cell death  
4 Dense necrosis, large confluent areas of cell death  
 
Neovascularization 
Microscopic blood vessels formed during the healing process of granulated tissue 
Score  Description  
0 No neovascularization present  
1 Mild neovascularization, some small capillaries present  
2 
Moderate neovascularization, larger artery(ies) or groups of capillaries 
present 
3 
Dense neovascularization, both larger arteries and accompanying small 





















Fibrotic capsule developed during innate foreign body immune response 
Score  Description  
0 No capsule present 
1 
Mild capsule of macrophages adjacent to implant and some (a few) 
fibrous cell layers  
2 
Moderate capsule composed of macrophages adjacent to implant and 
multiple/several layers of fibrous tissue (fibroblasts) 
3 
Dense capsule composed of three major sections: macrophages adjacent 




Presence of adipose tissue above/within the implant 
Score  Description  
0 No adipose tissue present  
1 Minimal amount of fat cells present in the area 
2 Several layers of adipocytes present near the implant  
3 
Elongated and broad accumulation of adipocyte cells about the implant 
site 


















Degradation of Implant 
Fragmentation of implant in situ 
Score  Description  
0 No visible degradation present  
1 
Sparse degradation of implant, some minor dissolution on edges, cracks 
in implant and/or small fragment present,   
2 
Mild degradation of implant with cracks in implant and/or some 
fragments, minor cellular infiltration  
3 
Moderate degradation of implant with presence of several fragments, 
clear cellular infiltration into the implant  
4 Abundant degradation of implant with almost complete fragmentation  
 
Table 5.1 Modifications to the ISO 10993-6 Standard. The cellular and tissue 
evaluation proposed by the International Organization for Standardization calls for 
the cell count of several inflammatory cells in each evaluated image (high powered 
400X).  Since the lowest magnification we were able to obtain was 20X, we tailored 
the analysis by redefining each score value, mimicking the terminology used in the 
ISO and included an additional section ‘Degradation of Implant’ to better describe 
how the host tissue is integrating with the degradable components of the hybrid 
scaffolds. 
 
Five blind scorers evaluated a total of 120 H&E images, of which 6 images 
corresponded to the center section of each hybrid scaffold.  For each sample, three of 
these images described the tissue response located at the implant-subcutaneous space 
interface, while the other three images described the tissue response at the implant-
fascia interface (Figure 5.1B).  Taken together, these six images per implant 
holistically represent the foreign body and vascular responses induced by the host.  
Figures 5.2 through 5.4 graphically depict the score averages in every evaluation per 
scaffold type, where each color (red, yellow, green, blue, and purple) represents the 





peak population incidence of each interface.  Since an even spread can be seen 
between averaged score value and color, there was a clear agreement amongst the 
results and the methodology of scoring can be viewed as consistent.  In general, there 
appeared to be a lower immune response from the underlying fascial tissues 
compared to those analyzed in the upper subcutaneous interface.  This may be due to 
the imbalanced, yet natural, cellular presence in the matrix of each neighboring tissue 
type; the fascia is predominantly composed of extracellular matrix (tightly wound 
collagen and elastin fibrils) with little vasculature and few cellular constituents of 
mainly fibroblasts223, while the subcutaneous pocket experiences a high influx of 
immune cells as it directly contacts the rat’s skin.  To serve its function as a 
protective barrier, the epidermis is highly composed of immune cells, such as 
Langerhans cells, neutrophils, mast cells, and dendritic cells, that defend against 
microbial pathogens, physical, or chemical threats to the host224.  Therefore, the 
subcutaneous interface is more likely to experience a heightened foreign body 
response and thus receive higher scores due to the increased immune cell migration 
rate from the epidermal layer.  Specific differences between fascial and subcutaneous 








Figure 5.1 Animal Surgery and Method for Capturing Images.  A. Three hybrid 
scaffolds were subcutaneously implanted in the dorsal lumbar region of each rat.  
Two incisions were made, the first was the initial 20 mm dorsal midline incision over 
the thoracolumbar area, and the second was through the superficial cervical fascia (a 
thin layer of subcutaneous connective tissue).  This allowed the implant to be 
stabilized, as tacking sutures resisted significant movement of the implant. B. Six 
images were taken for each central section in every resected implant.  We defined the 
location of each image by the length of the scaffold’s areola to normalize this process 





Representative images taken before implantation and D. after resection, where all 
samples appear to have maintained a nipple projection with minimal fibrotic capsule 
development. Scale bars represent 3 mm.   
 
5.3.2 Cellular Characteristics of Surrounding Host Tissue 
The score results recorded a range of mild to moderate cellular infiltration that 
was dependent on the implanted hybrid scaffold type.  Inflammatory infiltrate 
referred to the cells that appeared to be either lymphocyte, plasma, or 
polymorphonuclear granulocyte-like in appearance, which were generally cells 
exhibiting a single and rounded and/or lobed nucleus with little cytoplasm.  
Phagocytosis referred to the macrophage-like cells, such as those with multiple nuclei 
(multinucleated giant cells) and a large cytoplasm loaded with particular debris.  The 
infiltration of both cell groups was primarily observed in the implant-subcutaneous 
interface, as visualized by the higher peaks of the gray violin curves (Figure 5.2A 
and B).  The presence of lymphocytes and polymorphonuclear neutrophilic 
granulocytes is frequently associated with the early acute inflammatory response to 
the surgical procedure, and unfortunately their role in the local reaction to the implant 
is not known213.  However, they may be important for the ensuing macrophage 
response.  The primary function of these macrophages is the phagocytosis and 
clearance of the degradable parts of the implant, which is reflected in the high 
macrophage presence in hybrid scaffolds 1:1, 1:2, 1:3, and GelMA controls.  For non-
degrading implants, such as the PEG control, phagocytosis is not possible and the 
implant becomes encapsulated, which is also reflected in both the H&E images 
shown in Figure 5.2 and the pink and gray violin curves in Figure 5.2D.  Overall, 





the cellular response.  Some groups have reported that the dominance in macrophage 
cell type is indicative of a chronic inflammatory response225,226; however, in 
biodegradable regenerative scaffolds this represents a positive result, as the 
macrophages play a critical role in the maintenance and resolution of inflammation227 
while the natural materials hydrolyze as host cells infiltrate the scaffold.  The initial 
chronic inflammation can be most likely associated with the general wound healing 














Figure 5.2 Cellular Characteristics. A. Representative H&E 2X images pertaining to 
each scaffold type display a prominent nipple projection. B. Semiquantitative scoring 
evaluations for inflammatory infiltrate (pertaining to lymphocytes, plasma cells, and 
polymorphonuclear granulocytes) were evaluated by five blind scorers. On the left, 
colored dots (red, yellow, green, blue, and purple) represent the average score results 
in every scaffold type evaluation. On the right, a violin curve (type: kernel density 
estimation) portrays the probability density function of the averaged scores and 





subcutaneous interface, while FA refers to the fascia-implant interface).  Results 
show a lower inflammation of immune cells in FA than in SC interfaces, with 
minimal-moderate infiltrate present  C. Phagocytosis refers to the presence of 
macrophages, and the results depicted here show a dominating macrophage presence 
over other inflammatory infiltrate. D. Representative H&E 20X images that portrayed 
the cellular characteristics in and around the scaffolds.  Scale bars represent 100 µm.  
 
 
5.3.3 Tissue Characteristics of Surrounding Host Tissue 
As the cellular characteristic scores of the host response point towards the 
signs of a healthy recovery, the tissue characteristics of the surrounding host tissue 
also reveal a general acceptance of the implant.  Intuitively, the implants containing 
the most GelMA experienced the highest degradation; score trends depict the GelMA 
control exhibited the most degradation, followed by the 1:3 pattern, 1:1 and 1:2 
patterns with fairly equal amounts of degradation, and finally the PEG control 
exhibiting the least amount (Figure 5.3A).  There appears to be a striking contrast in 
score trends between the subcutaneous and fascia interface within the GelMA implant 
test group, where the fascia-implant interface displayed a higher amount of 
degradation.  One possible explanation for this finding would be that the fascia 
interface experiences a higher shear load along its boundary as the animal 
moves/walks, and this contraction of underlying muscle may cause mechanical 
friction that enhances the degradation rate of the implant.  Degradation is favorable in 
regard to our implant, as its hybrid material makeup is designed to promote 
integration with the surrounding host tissue and thus lead to an interlocked placement 






Additionally, neovascularization was recorded (Figure 5.3B) and is another positive 
trait that signifies the formation of granulation tissue.  Granulation tissue is a young 
connective tissue that grows from the base of a wound and contains proliferative 
fibroblasts, delicate capillaries, and infiltrated inflammatory cells in a loose cellular 
matrix228.  Its presence resembles a positive result, as its formation means that both 
inflammatory responses (acute and chronic) have subsided, and new, healthy tissue is 
beginning to form.  Neovascularization is present in all the implant types tested, with 
GelMA controls, 1:1, and 1:2 scaffolds exhibiting the highest number of capillaries 
present.  These results were later validated with quantitative measurements taken 
from the H&E images, by which the number of blood vessels within each image was 







Figure 5.3: Tissue Characteristics 1, Degradation of Implant and 
Neovascularization of Surrounding Tissue.  A. Degradation of the biodegradable 
GelMA is expected in patterns containing the highest amount of this biomaterial (i.e. 
1:3 and GelMA 0:1 control), and the average score results reflect this prediction.  A 
striking contrast exists between FA and SC interfaces, which may be due to the 
increased shear stress induced by the contraction of underlying fascial muscles.  B. 





tissue is beginning to form.  C. Blood vessels were counted in each 20X (n’=6 with 
n=4 biological samples) image and recorded to validate our previous blind score 
results. These quantitative image results display mean ± standard deviation and were 
analyzed using a two-group Paired Comparison plot followed by Tukey’s Multiple 
Comparison Test assuming normal data distribution with a confidence of 95% 
(p<0.05). D. Representative H&E 20X images that display evidence of 
neovascularization in every scaffold type, where a red arrow points to the location of 





Adipocyte proliferation is often stimulated as granulation tissue forms229, which 
aligns with the variable amount of fatty infiltrate that was recorded among the hybrid 
implant types (Figure 5.4A).  Large adipose vacuoles were visualized along the 
subcutaneous interface in hybrid patterns 1:1, 1:2, and 1:3.  Remarkably, the PEG 
controls also experienced a mild infiltration of adipose tissue.  This fatty infiltrate 
may have stemmed from the migration and proliferation of adipocytes derived from 
the hypodermis of the rat skin, and its presence could ultimately be beneficial in the 







Figure 5.4: Tissue Characteristics 2, Presence of Fatty Infiltrate. A. The 
subcutaneous interface experiences a proliferation of adipose tissue, which can be 
visualized by the high peaks of the gray violin curves.  Large adipose vacuoles can be 
visualized in representative H&E images depicted in B (images taken at the implant-
subcutaneous interface) and C (images taken at the fascia-implant interface). Scale 






The last and most promising recorded tissue characterization was the minimal capsule 
thickness surrounding each implant.  Capsular contracture is a very common, painful, 
and detrimental complication that accompanies many soft tissue implants230, 
especially those used in breast reconstruction.  In fact, the overall incidence of 
capsular contracture of silicone breast implants is reported as high as 37% and 
increases up to 100% in studies with patients receiving post-mastectomy radiation 
therapy (PMRT)231, requiring a further surgical procedure (capsulotomy or 
capsulectomy).  Even with current design strategies of textured surface topologies232, 
advanced surgical techniques, and supplemental steroids and antibiotics233, capsular 
contraction still remains a significant threat to the patient’s health.  Our hybrid 
scaffolds exhibited an average fibrotic capsule score in a mild – moderate range in 
severity.  As before, the implant-subcutaneous interface experienced a higher 
inflammation and thus foreign capsule response around the implant than the fascia-
implant interface due to the migration of epidermal immune cells.  Scaffolds with the 
highest GelMA component (1:3 hybrid, GelMA control) and PEG controls displayed 
trends in a mild fibrotic capsule formation (Figure 5.5).  Hybrid scaffolds 1:1 and 1:2 
appeared to have a more moderate capsule, where several layers of fibrous tissue 
were present.  To validate the semiquantitative scoring results, sample sections were 
stained with MT and subsequent quantification of the fibrotic capsule was measured.  
The mean thickness of the capsules was larger at the subcutaneous interface (1:1 
recorded the thickest measurement of 378.87 ± 108.45 micros) than the fascial 
interface (1:2 recorded the thickest measurement at 244.08 ± 35.63 microns), 





fibroblast layer were drastically reduced in the PEG control group (199.79 ± 94.63 
µm at SC surface and 39.16 ± 8.97 µm at the FA interface) when compared to the 1:1 
and 1:2 hybrid scaffolds.  Outstandingly, the 1:3 hybrid scaffold experienced a 
minimal capsule encapsulation of 250.43 ± 62.74 µm at the SC interface and 128.89 ± 
61.49 µm at the FA interface.  Other groups have recorded fibrotic capsules up to 3 
mm in thickness when synthetic materials have been implanted subcutaneously in a 
rat model121.  This rigorous semiquantitative study confirms the effectiveness of these 
hybrid materials in subsiding significant acute and chronic inflammations and thus 








Figure 5.5: Tissue Characteristics 3, Capsule Characterization. A. With all 
foreign objects introduced to the body, a fibrotic capsule forms at the boundary of the 
implant and is composed of giant nucleated macrophage cells and surrounding 
fibroblasts.  Scoring results show that the capsule exists in a mild-moderate thickness. 
This was further quantified in B, where each image was evaluated at 3 separate points 
(n’=6, n=3).  These quantitative image results display mean ± standard deviation and 
were analyzed using a two-group Paired Comparison plot followed by Tukey’s 
Multiple Comparison Test assuming normal data distribution with a confidence of 
95% (p<0.05). C. Representative Masson Trichrome images for capsule quantitative 













Taken together, these results suggest that a hybrid nipple-areola acellular scaffold has 
great potential in reconstructing the nipple.  The inflammatory reaction was mainly 
characterized by the presence of macrophages, with moderate neovascularization, 
variable amounts of fatty infiltration, high degradation, and minimal fibrotic capsule 
thickness.  Given that the foreign body response is a multifactorial event cascade, and 
that we have only examined the process after 4 weeks, further studies are needed to 
evaluate the long-term success of the implant.  In addition, our sterilization practice 
requires improvement, as there were wound-healing defects present at two incision 
sites.  Strategies can be taken to prevent bacterial infection and to modulate implant 
rejection, such as anti-inflammatory cytokine release from the scaffold and immune 





Chapter 6:  Summary and Future Directions 
 
6.1 Summary 
In this dissertation, we combined the essence of conventional tissue 
engineering with a modern 3D printing platform to completely reimagine effective 
strategies for nipple reconstruction.  As many groups have previously shown, the 
nipple-areola complex constitutes an important landmark on the breast and its loss 
due to breast cancer treatment can have devastating psychological effects on the 
patient.  By replacing standard SFS techniques with a tissue engineered nipple-areola 
graft, the resulting nipple is designed to exhibit less flattening, provide an opportunity 
to regenerate part of the breast, and result in an appearance that more closely mimics 
the previous natural tissue.  Extrusion 3D printing is an excellent fabrication 
technique to create custom shaped nipple-areola grafts per any breast size, as it has 
become an advantageous method that can incorporate digital information from CT 
scans directly into the final product.   
 
The first objective of this work was to develop a hybrid printing platform that 
incorporated the strengths of natural and synthetic materials for the fabrication of soft 
tissue constructs.  In Chapter 3, we developed a synthetic double-network ink 
composed of covalently crosslinked poly(ethylene glycol) and ionically crosslinked 
alginate capable of withstanding high compressive forces (>30kPa fracture strength, 





biodegradable gelatin methacrylate bioink in various print patterns, we were able to 
produce hybrid soft tissue constructs with moduli scaling a fourfold variation in 
stiffness – a range congruent to the stiffness values found in various compositions of 
soft tissue (skeletal muscle, 500 kPa, to adipose tissue, 10 kPa, compressive moduli 
values).   Additionally, we defined a new shape analysis technique utilizing 
CloudCompare software to further assess the aesthetic properties of the printed 
scaffolds.  With point cloud comparisons and quantitative measurements, a gradient 
in shape maintenance was found that was dependent on the print pattern used during 
scaffold fabrication.  The conclusion of this aim resulted in the production of a 
biomimetic hydrogel graft consisting of both degradable and nondegradable parts that 
seamlessly coexist to promote tissue integration while maintaining its original printed 
structure.  
 
In Chapter 4, we further tailored this hybrid printing strategy specifically to nipple 
tissue engineering.  Methylcellulose was substituted for alginate, as its hydrophobic 
interactions produced a stable double network hydrogel more appropriate for in vivo 
implantation.   We then demonstrated successful fabrication of physiologically sized 
nipple-areola constructs and found the mechanical properties of these hybrid scaffolds 
mirrored those of natural nipple tissue.  Once the design of the bioprinted nipple was 
established, we wanted to determine the effect of the hybrid print pattern on internal 
cell viability and shape maintenance when human dermal fibroblasts were 
encapsulated in the GelMA bioink.  When implanted in vivo, commercial products 





inadequate diffusion between the wound bed and autograft38,93,94.  Additionally, 
dermal fibroblasts have been recorded to displace significant contractile forces on 
their substrate, and this behavior has resulted in the warping of many documented 
skin grafts36,170.  We found that the majority of the tested print patterns produced a 
composite matrix that provided adequate diffusion to support cellular proliferation 
and exhibited minimal projection deformation when subjected to the highest level of 
cellular contractile forces.  These results showcased the in vitro capacity of our hybrid 
scaffolds to provide accurate physical cues for nipple-areola reconstruction.  
 
Our final investigation in Chapter 5 was focused on the integration of these hybrid 
prints with host tissue in a rat subcutaneous model.  Five blind scorers evaluated the 
histological responses by utilizing a modified ISO 10993-6 Standard, meticulously 
assessing the cellular and tissue characteristics both in and around the implant.  In 
most cases, a mild local foreign body reaction was observed, with minimal 
encapsulation and a moderate infiltration of inflammatory cells.  The apparent 
formation of granulation tissue signified that both inflammatory responses (acute and 
chronic) had subsided in most implant types, and a new connective matrix with 
proliferative fibroblasts and delicate capillaries was beginning to form.  
Histomorphometric analysis also revealed moderate vascularization around the 
implant (5-10 blood vessels/mm2) and an average 200-400µm in capsule thickness.  
These results are encouraging, as comparable studies have recorded an average 






In conclusion, the success of our in vitro and in vivo trials suggest that these hybrid 
nipple-areola complex scaffolds can provide a promising solution to nipple 
reconstruction.  The acellular 3D printed scaffold contains a complementary matrix 
that can both recruit host dermal cells and withstand contractile forces, which can be 
used to better reproduce a well-integrated and stable nipple projection.  The ability to 
scan the existing breast of the patient via computed tomography (CAT) and replicate 
the exact dimensions of that nipple-areola complex greatly appeals to nipple tissue 
reconstruction.  In contrast to traditional fabrication methods (involving molds or 
solvents), 3D printing can easily create these unique grafts by incorporating their 
complex structure from the bottom-up in a layer-by-layer fashion.  The customization 
and the regenerative potential of this strategy also prioritizes the emotional health of 
the mastectomy patient, enabling this implant to be viewed as a more appropriate 
nipple reconstruction technique for breast cancer survivors.  
 
6.2 Future Directions  
Even with the excitement and early success of this work, there are many 
hurdles to be addressed before this tissue engineering strategy reaches its eventual 
goal to aid thousands of breast cancer survivors.  In addition to efficacy, scale-up 
potential, reliability, established regulatory routes, and societal acceptance issues, 
there are many technical challenges to overcome.  Some of the major challenges are 







Vascularization, the formation and growth of blood vessels, is a major 
engineering hurdle to overcome when creating artificial tissues, particularly large-
scale 3D tissues.  The internal formation of blood vessels is critical for the function 
and survival of cells because this integrated network provides effective transport of 
oxygen, nutrients, and removal of cell-secreted waste.  Some groups have reported 
that it is particularly important for cells to be located within 250 µm of an oxygen 
source to thrive and function234.  Therefore, to effectively develop a viable nipple 
projection, we must encourage the formation of vasculature with either physical or 
biochemical cues throughout the center of the implant.  In preliminary studies, we 
have printed Pluronic (a sacrificial sucrose ink) that can further be washed away to 
produce intricate lumen strands with predefined structures (Figure 6.1).  Human 
umbilical vein endothelial cells (HUVECs) can be directly introduced into these open 
channels to create progenitor vessels that can be further matured in a bioreactor.  For 
an acellular approach, angiogenic factors, such as fibroblast growth factors (FGF) and 
vascular endothelial growth factors (VEGF) can be incorporated into the bioinks to 
stimulate host endothelial cell migration into these open vessels.  Further studies 







Figure 6.1: Sacrificial lumen-like channels to guide vascularization of nipple 
projection 
6.2.2 Nipple-Areola Skin Graft 
The vision for this implant is a viable nipple-areola skin graft, derived from 
the patient’s skin cells, that can be directly sutured onto the breast to disrupt the 
central mastectomy scar prominence.  The addition of dermal fibroblasts to the 
GelMA bioink and a topical application of epidermal keratinocytes could produce a 
viable skin substitute if matured prior to implantation.  Due to the height of the 3D 
printed nipple projection (8mm), it could be difficult to cultivate in vitro due to a lack 
of diffusion within its elevated shape (>250 µm from the nearest nutrient source).  To 
address this hurdle, we suggest that a bioreactor culture system is necessary to 
appropriately mature these grafts.  Currently, we have made great progress towards 
this goal; we have developed an inverted bioreactor capable of effectively hydrating 
the dermal compartment of the graft with gravity-driven media diffusion while 





exposure has been shown to be critical in the proper stratification of keratinocytes to 
produce an epidermal barrier36, therefore submerging the grafts in media (per typical 
skin graft culture) would have negative impacts on the maturation of the nipple-areola 
skin graft.  Preliminary studies have shown promising keratinocyte monolayer 
formation with positive cytokeratin 10 staining along with a viable nipple projection 
containing dermal fibroblasts, yet further studies are needed to visualize skin graft 













6.2.3 4D Bioprinting 
One major drawback of 3D printing is that both the initial and final states of 
the fabricated object remain static.  An inanimate, 3D printed nipple projection does 
not mimic the movements of the natural tissue; normally, smooth muscle erector pili 
cells line the base of the projection and can contract or elongate depending on the 
stimuli, resulting in a gradual projection or retraction of the nipple.  Plastic surgeons 
have reported that some women prefer a nipple-areola tattoo over the SFS procedure 
because they dislike the constant ‘stimulated’ state of the reconstructed nipple235,236.  
Therefore, the incorporation of a 4th dimensional printing technique, where the 3D 
object is capable of changing its shape or functionality in respect to time, can enhance 
the design to be more dynamic with the host tissue.  Existing 4D printed objects are 
mainly inspired by botanical systems (curling of tendrils, leaves, and flowers), 
primarily rely on physical stimuli, and are fabricated with temperature, pH, water, 
electric, magnetic, light, or acoustic-responsive materials237–239.  However, I believe 
the most compelling potential of 4D printing will be the controlled movement of 
scaffold structures induced by stimulated cells (chemically, driven by ions or growth 
factors) to reshape or transform the state of the tissue scaffold.  Below are snapshots 
of an animation that models a dynamic contraction/projection of a nipple, where a 
boundary contractile force is applied to the projection’s base.  This force is 
theoretically induced by matured smooth muscle cells that have been encapsulated 
(and printed) in the GelMA compartments of the scaffold (light pink regions).  By 
creatively designing the synthetic backbone architecture (dark purple regions), we can 





state.  The development of a 4th dimensional printing technique that adds a responsive 
functionality to the printed nipple-areola skin graft can further enhance the implant’s 
design and be one incredible scientific invention!  
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